Download as xls, pdf, or txt
Download as xls, pdf, or txt
You are on page 1of 118

FDA Citizen Petition Tracker

Docket No. Petitioner Product Name/Issue Category

FDA-2017-P-1108 Orbicular TIMOPTIC (Timolol Maleate) Drug


Pharmaceutical Ophthalmic Solution, 0.25%
Technologies and 0.5%
FDA-2017-P-1104 Gator Pharmaceuticals, Colon Preparation Kits Drug
Inc. (COLPREP Kit)

FDA-2017-P-1096 Hyman, Phelps & VASOSTRICT (vasopressin) Drug


McNamara, P.C. Injection, 20 units per mL

FDA-2017-P-1039 Beck & Thomas Potassium Chloride Oral Drug Drug


Products

FDA-2017-P-1002 Inrange Systems, Inc. Product Detention Medical


Device

FDA-2017-P-0970 RiceBran Technologies Rice Bran/Rice Fiber Food

FDA-2017-P-0868 David Wong Quetiapine Fumerate Drug


Extended-Release Tablets 180-
Day Exclusivity
FDA-2017-P-0867 Public Citizen HES IV Solutions Drug

FDA-2017-P-0866 Hyman Phelps & THIOPLEX (thiotepa) for Drug


McNamara, P.C. Injection, 15 mg/vial

FDA-2017-P-0864 Hyman Phelps & Ibuprofen Tablets, 200 mg Drug


McNamara, P.C.

FDA-2017-P-0863 Fresenius Kabi USA, Sodium Chloride 23.4% Drug


LLC Injection USP, 100 mL and 200
mL
FDA-2017-P-0840 The Weinberg Group OVRETTE (norgestrel) Tablets Drug

FDA-2017-P-0757 Vertice Pharma, Inc. Potassium Chloride Oral Drug Drug


Products
FDA-2017-P-0663 Mucodel Pharma, LLC Intranasal Naloxone Drug

FDA-2017-P-0662 Impax Laboratories, Inc. RYTARY (carbidopa and Drug


levodopa) Extended-release
Capsules
FDA-2017-P-0508 Union of Concerned Added Sugars Food
Scientists, Center for
Science and
Democracy

FDA-2017-P-0495 Lachman Consultant CORDARONE (amiodarone Drug


Services, Inc. HCl) Tablets, 200mg

FDA-2017-P-0494 Navinta LLC Sodium Phenylacetate and Drug


Sodium Benzoate injection,
10%/10%, 20 ml fill volume
FDA-2017-P-0428 Mucodel Pharma LLC Intranasal Naloxone Drug

FDA-2017-P-0398 Florek & Endres PLLC Hydromorphone HCl Extended- Drug


release Tablets, 24 mg

FDA-2017-P-0290 Malaysian Rubber Powdered Gloves Medical


Export Promotion Device
Council
FDA-2017-P-0176 American Herbal Sperm Donation Industry Dietary
Products Association Supplement

FDA-2017-P-0137 Macleods Pyrazinamide Tablets 500 mg Drug


Pharmaceuticals
Limited
FDA-2017-P-0115 Jubilant Generics Levetiracetam Injection, Drug
Limited 1000mg/10 ml and 1500 mg/15
ml
FDA-2017-P-0052 Donor Sibling Registry Sperm Donation Industry Misc
Petition Tracker
LAST UPDATED: 2/27/2017

Petition Type Receipt Date Decision Date Decision

Citizen Petition - 2/22/2017 Pending


Listed Drug
Discontinuation
Citizen Petition 2/21/2017 Pending

Citizen Petition - 2/17/2017 Pending


Listed Drug
Discontinuation
Citizen Petition 2/16/2017 Pending
(505(q) Certification)

Citizen Petition 2/13/2017 Pending

Citizen Petition 2/13/2017 Pending

Citizen Petition 2/8/2017 Pending

Citizen Petition 2/8/2017 Pending

Citizen Petition - 2/8/2017 Pending


Listed Drug
Discontinuation
Citizen Petition - RLD 2/8/2017 Pending
Designation

Citizen Petition - 2/8/2017 Pending


ANDA Suitability
Petition
Citizen Petition - 2/8/2017 Pending
Listed Drug
Discontinuation
Citizen Petition 2/3/2017 2/10/2017 Withdrawn
(505(q) Certification)
Citizen Petition 1/31/2017 Pending
(505(q) Certification)

Citizen Petition 1/31/2017 Pending


(505(q) Certification)

Citizen Petition 1/25/2017 Pending

Citizen Petition - 1/25/2017 Pending


Listed Drug
Discontinuation
Citizen Petition - 1/25/2017 Pending
ANDA Suitability
Petition
Citizen Petition 1/20/2017 2/8/2017 Withdrawn
(505(q) Certification)

Citizen Petition - 1/18/2017 Pending


ANDA Suitability
Petition
Citizen Petition 1/16/2017 Pending

Citizen Petition 1/9/2017 Pending

Citizen Petition - RLD 1/9/2017 Pending


Designation

Citizen Petition - 1/5/2017 Pending


ANDA Suitability
Petition
Citizen Petition 1/3/2017 Pending
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2016-P-4587 Mallinckrodt INOmax (nitric oxide) Drug


Pharmaceuticals

FDA-2016-P-4585 Acorda Therapeutics, AMPYRA (dalfampridine) Drug


Inc. Extended-release Tablets

FDA-2016-P-4584 Public Citizen Health Repaglinide-containing Drug


Research Group Medications (PRANDIN,
PRANDIMET)
FDA-2016-P-4388 Dr. S. Varghese Loperamide (Imodium) - OTC- Drug
to-Rx Switch

FDA-2016-P-4341 Osmotica Venlafaxine HCl Extended- Drug


Pharmaceutical US LLC release Tablets, 225 mg

FDA-2016-P-4275 BioNeutra North Dietary Fibers - Isomalto- Food


America Inc. oligosaccharides

FDA-2016-P-4274 Teligent, Inc. Mupirocin Ointment 2% Drug

FDA-2016-P-4233 KFSU Ltd. Sugarcane Flour Food

FDA-2016-P-4186 Lachman Consultant CALCIMAR (calcitonin salmon) Drug


Services, Inc. Injection, 200 IU/mL

FDA-2016-P-4164 Lachman Consultant Carbinoxamine Maleate Orally Drug


Services, Inc. Disintegrating Tablets, 2 mg, 4
mg, 6 mg and 8 mg
FDA-2016-P-4141 Upsher-Smith QUDEXY XR (topiramate) Drug
Laboratories, Inc. Extended-release Capsules
(TE Rating)
FDA-2016-P-4095 Mapi USA, Inc. Carglumic Acid Tablets, 50 mg Drug
(Medunik Canada Ltd.) and 200 mg

FDA-2016-P-4094 Adapt Pharma Intranasal Naloxone Drug


Operations Ltd.
FDA-2016-P-4093 Ferring Desmopressin to Treat Drug
Pharmaceuticals Inc. Nocturia

FDA-2016-P-4047 Mayne Pharma DORYX MPC (doxycycline Drug


lnternational Pty Ltd. hyclate) Delayed-release
Tablets
FDA-2016-P-3968 International Probiotics Dietary Supplement Labeling Food
Association

FDA-2016-P-3912 Adapt Pharma NARCAN (naloxone) Nasal Drug


Operations Ltd Spray

FDA-2016-P-3823 Jennifer A. Osler TBD TBD

FDA-2016-P-3753 MacLeods Diclofenac Sodium Topical Drug


Pharmaceuticals Solution, 1.5%
Limited
FDA-2016-P-3696 ANDA Consultants FML (fluorometholone Drug
ophthalmic Suspension)

FDA-2016-P-3674 Consumers for Dental Dental Amalgum Drug


Choice

FDA-2016-P-3620 MGP Ingredients, Inc. Modified Wheat Starch Food


(Fibersym® RW and
FiberRite® RW)
FDA-2016-P-3598 Axinn, Veltrop & EVOLMELA (melphalan HCl) Drug
Harkrider LLP for Injection, Eq. 50 mg
base/vial
FDA-2016-P-3560 Orchid Healthcare CEDAX (Ceftibuten for Oral Drug
Suspension)

FDA-2016-P-3510 Zhuhai Kinhoo Cefadroxil Chewable Tablets Drug


Pharmaceutical Co., 125 mg and 250 mg
Ltd.
FDA-2016-P-3509 Metabolic Therapy Inc. OTC External Analgesics - Drug
Melatonin and Inositol
hexaphosphate
FDA-2016-P-3482 Zydus Pharmaceuticals LYNPARZA (olaparib) Drug
(USA) Inc Capsules, 50 mg

FDA-2016-P-3465 Novitium Pharma LLC Ranitidine Capsules, 150 mg Drug


and 300 mg

FDA-2016-P-3463 Axinn, Veltrop & Apixaban Tablets, 10 mg Drug


Harkrider LLP

FDA-2016-P-3428 Felix Pharmaceuticals Cefpodoxime Proxetil Animal Drug


Pvt. Ltd. Chewable Tablets
FDA-2016-P-3427 Felix Pharmaceuticals Carprofen Chewable Tablets Animal Drug
Pvt. Ltd.

FDA-2016-P-3426 Novitium Pharma LLC Minipress Capsules, EQ 2mg Drug


base

FDA-2016-P-3418 Salix Pharmaceuticals, XIFAXAN (rifaximin) Tablets Drug


Inc.

FDA-2016-P-3356 Sandoz Inc. ADVAIR DISKUS100/50 Drug


(fluticasone propionate 100
mcg and salmeterol 50 mcg
inhalation powder)

FDA-2016-P-3313 Purdue Pharma L.P. BUTRANS (buprenorphine) Drug


Transdermal System

FDA-2016-P-3312 Gilead Sciences, Inc. STRIBILD (elvitegravir, Drug


cobicistat, emtricitabine,
tenofovir disoproxil fumarate)
Tablets

FDA-2016-P-3311 Tate & Lyle Ingredients Polydextrose Food


Americas LLC/DuPont
Nutrition & Health
FDA-2016-P-3195 Wood, Herron & Evans, MagnaTouch MRI Music Medical
LLP System, Genesis Ultra MRI Device
Music System, MagnAlarm
FDA-2016-P-3162 ANDA Consultants Terbutaline Sulfate Tablets, 5 Drug
mg

FDA-2016-P-3112 Mario Morais Citizen Petition Response Misc


Timeframes

FDA-2016-P-3089 Aleon Pharma Cefixime Tablet for Oral Drug


International, Inc. Suspension 50mg, 100mg, and
200mg
FDA-2016-P-3082 Pfizer Inc. DUAVEE (conjugated Drug
estrogens/bazedoxifene)

FDA-2016-P-3070 DuPont Nutrition & Soy Fiber Food


Health

FDA-2016-P-3052 Lehigh Valley Unapproved Drugs - Drug


Technologies, Inc. Enforcement Action

FDA-2016-P-3015 Felix Pharmaceuticals Enrofloxacin Taste Tab Animal Drug


Pvt. Ltd. Antibacterial Tablet

FDA-2016-P-2955 Nicholas Isel Sperm and/or Egg Donation Biologics


Assisted Reproductive
Technology
FDA-2016-P-2860 General Mills, Inc Dietary Fiber Food

FDA-2016-P-2782 Alcon Pharmaceuticals, CIPRODEX (ciprofloxacin 0.3% Drug


Ltd. and dexamethasone 0.1%)
Otic Suspension
FDA-2016-P-2781 Alcon Pharmaceuticals, DUREZOL (difluprednate Drug
Ltd. ophthalmic emulsion) 0.05%

FDA-2016-P-2738 Metabolic Therapy Inc. OTC Acne Drug Products Drug


Monograph (Chromium)

FDA-2016-P-2737 Natural Resources Antibiotics in Livestock and Animal Drug


Defense Council Poultry

FDA-2016-P-2736 Beneo, Cosucra Inulin-type Fructans Derived Food


Groupe Warcoing S.A., from Chicory Root as
and Sensus B.V. Dietary Fiber
FDA-2016-P-2713 Strides Pharma Inc. Amantadine Hydrochloride, Drug
Capsule, 100 mg

FDA-2016-P-2676 Joshua Schroeder Misbranded Major Food Food


Allergens and Adulterated
Foods
FDA-2016-P-2675 Foley & Lardner LLP GYNOREST (dydrogesterone) Drug
Tablets

FDA-2016-P-2674 Heritage Pharma, Inc. CALAN SR (Verapamil HCl) Drug


Sustained-release Tablets, 180
mg
FDA-2016-P-2672 Jazz Pharmaceuticals XYREM (sodium oxybate) Drug
Inc.

FDA-2016-P-2654 Vanda Fanapt (Iloperidone) Tablets Drug


Pharmaceuticals, Inc.

FDA-2016-P-2568 Fresenius Kabi USA Sodium Chloride in Plastic Drug


Container (2.5 mEq/mL)

FDA-2016-P-2559 Emord and Associates, Electroconvulsive Therapy Medical


P.C. Devices Device

FDA-2016-P-2558 Similasan Corporation Homeopathic Pink Eye Drug


Remedies for OTC Use

FDA-2016-P-2533 American Feed Industry Electronic Records - Veterinary Animal Drug


Association and Feed Directives
National Grain and
Feed Association

FDA-2016-P-2532 David K. Cundiff Vitamin K2 Intakes Food


FDA-2016-P-2515 Eli Lilly and Company FORTEO (teriparatide [rDNA Drug
origin] injection)

FDA-2016-P-2497 Clinical Decision Digital Health Pharmaceutical Drug/Device


Support Coalition Products

FDA-2016-P-2478 United Therapeutics TYVASO (treprostinil) Drug


Corporation Inhalation Solution

FDA-2016-P-2469 Hyman, Phelps & SYMMETREL (amantadine Drug


McNamara, P.C. hydrochloride) Syrup, 50 mg/5
mL
FDA-2016-P-2467 Actavis LLC Azacitidine for Injection, 100 Drug
mg/vial

FDA-2016-P-2377 Archer Daniels Midland Fibersol resistant maltodextrin Food


Company as Dietary fiber

FDA-2016-P-2376 Par Sterile Products, ADRENALIN (epinephrine Drug


LLC injection) 1 mg/mL, 1 mL vial

FDA-2016-P-2375 AKORN Specialty Furosemide Injection, 10 Drug


Generics mg/mL

FDA-2016-P-2344 ANDA Consultants Furosemide Injection, 10 Drug


mg/mL

FDA-2016-P-2342 Sovereign Metaxalone Tablets, 400 mg Drug


Pharmaceuticals, LLC and 640 mg

FDA-2016-P-2337 Lachman Consultant Leucovorin Calcium Injection Drug


Services, Inc. USP, 50 mg/5 mL, 100 mg/10
mL, 200 mg/20 mL, and 350
mg/35 mL

FDA-2016-P-2091 ANDA Consultants Furosemide Injection, 10 Drug


mg/mL

FDA-2016-P-2072 Pacific-Link Consulting Naloxone Containing Product Drug


(Adapt Pharma)

FDA-2016-P-2030 The Food Lawyers Allulose Food

FDA-2016-P-2029 Virtus Pharmaceuticals PDUFA User Fees Drug


OpCo, LLC

FDA-2016-P-1991 Felix Pharmaceuticals Carprofen Chewable Tablets Animal Drug


Pvt. Ltd

FDA-2016-P-1962 Allergan plc LINZESS (linaclolide) Capsules Drug


FDA-2016-P-1955 Mallinckrodt INOmax DSIR Plus Drug/Device
Pharmaceuticals

FDA-2016-P-1952 Fresenius Kabi USA, ROBINUOL (glycopyrrolate Drug


LLC injection)

FDA-2016-P-1946 Collegium Oxycodone ER Abuse- Drug


Pharmaceutical, Inc. Deterrent Drugs

FDA-2016-P-1875 Pacific-Link Consulting Prescription Dopamine Agonist Drug


(Adapt Pharma) Drugs

FDA-2016-P-1874 Public Citizen Health Prescription Dopamine Agonist Drug


Research Group Drugs

FDA-2016-P-1873 Teva Pharmaceuticals AMRIX (cyclobenzaprine HCl) Drug


Extended-release Capsules, 15
and 30 mg
FDA-2016-P-1852 Farm-To-Consumer Interstate Sales of Food
Legal Defense Fund Unpasteurized Butter

FDA-2016-P-1826 NuTek Food Science Potassium Salt Food


LLC

FDA-2016-P-1825 Lachman Consultant KENALOG-40 (triamcinolone Drug


Services, Inc. acetonide)
Injectable Suspension
FDA-2016-P-1725 Lachman Consultant Flonase (fluticasone Drug
Services, Inc. propionate) Nasal Spray, 0.05
mg
FDA-2016-P-1676 JR Rapoza Associates, Cyanocobalamin Injection 1000 Drug
Inc. mcg/mL in a 10 ml vial

FDA-2016-P-1674 Tate & Lyle Ingredients Soluble Corn Fiber Food


Americas LLC

FDA-2016-P-1667 Zydus Pharmaceutical ANTIVERT (Meclizine Drug


(USA) Inc Hydrochloride) Tablets, 12.5
mg and 25 mg
FDA-2016-P-1650 Lannett Company, Inc. Morphine Sulfate Oral Solution, Drug
100 mg/5 mL

FDA-2016-P-1547 Baxter Healthcare Levofloxacin Injection in 5% Drug


Corporation Dextrose

FDA-2016-P-1485 AstraZeneca CRESTOR (rosuvastatin Drug


Pharmaceuticals LP calcium)

FDA-2016-P-1398 Dr. Hooman Clearance of the Pneumoliner Medical


Noorchashm Containment System for use Device
with Power Morcellators
FDA-2016-P-1364 Lachman Consultant Paclitaxel for Injection Drug
Services, Inc. Suspension, in a 250 mg/vial
lyophilized powder
FDA-2016-P-1363 Gordon Johnston Sodium Chloride Injection Drug
Regulatory Consultants, 23.4%
LLC
FDA-2016-P-1319 Florek & Endres PLLC Daptomycin Powder for Drug
Intravenous Use, 350 mg/vial

FDA-2016-P-1314 Center for Responsible Skin and Eye Irritation Testing Drug
Science Methods

FDA-2016-P-1303 Consumers for Dental Dental Amalgum Drug


Choice

FDA-2016-P-1288 Fluoride Action Network Sodium Fluoride-containing Drug


Drops, Tablets, and Lozenges

FDA-2016-P-1287 Lachman Consultant Amphotericin B Liposome for Drug


Services, Inc. Injection, 250 mg/vial
lyophilized powder
FDA-2016-P-1286 Lachman Consultant Glycopyrrolate Injection, 0.1 Drug
Services, Inc. mg/0.5 mL

FDA-2016-P-1285 Mylan Pharmaceuticals Furosemide Injection, USP-10 Drug


Inc. mg/mL in 2 mL, 4 mL & 10 mL
fill
FDA-2016-P-1251 Lachman Consultant Busulfan Injection, 30 mg/5 mL Drug
Services, Inc.

FDA-2016-P-1250 PTS Consulting Chlorpromazine Hydrochloride Drug


Tablets, 100 mg

FDA-2016-P-1249 Haner & Kuo, PLLC Potassium Chloride Oral Drug


Solution

FDA-2016-P-1247 ABHAI, LLC METADATE ER Drug


(methylphenidate HCl)
Extended-release Tablets
FDA-2016-P-1246 Working Group on Low-dose Vaginal Estrogen Drug
Women's Health and Product Labeling
Well-Being in
FDA-2016-P-1213 Menopause and The
Medtech Products Inc. Acetaminophen 250 mg, Drug
North American Aspirin 250 mg, and Caffeine
Menopause Society 65 mg Powder
FDA-2016-P-1212 Medtech Products Inc. Acetaminophen 250 mg, Drug
Aspirin 250 mg, and Caffeine
65 mg Powder for Solution
FDA-2016-P-1211 Medtech Products Inc. Acetaminophen 250 mg, Drug
Aspirin 250 mg, and Caffeine
65 mg Chewable Tablets
FDA-2016-P-1180 Top Health Ingredients Isomaltooligosaccaride; List of Food
Inc. Dietary Fibers

FDA-2016-P-1171 Breast Cancer Fund et Ortho-phthalates Drug


al.

FDA-2016-P-1169 e5 Pharma LLC Methimazole Rapidly Drug


Disintegrating
Tablets

FDA-2016-P-1163 Vifor Fresenius Medical VELPHORO (sucroferric Drug


Care Renal Pharma oxyhydroxide)
France
FDA-2016-P-1158 Amanda Williams Food Allergen Information on Food
the Bulk Candy Packaging

FDA-2016-P-1133 ProbioTech LLC Probiotic Suppositories Dietary


Supplement

FDA-2016-P-1128 Melissa Schilling Glycemic Load of Packaged Food


Food

FDA-2016-P-1115 Mostyn Law Firm Class I recall of Products made Medical


with Counterfeit, Chinese Device
Resin
FDA-2016-P-1108 Gordon Johnston Dextrose 5% and Sodium Drug
Regulatory Consultants, Chloride Injection 0.9%
LLC Injection in Plastic Container
FDA-2016-P-1107 Gordon Johnston Dextrose 5% and Sodium Drug
Regulatory Consultants, Chloride Injection 0.225%
LLC Injection in Plastic Container
FDA-2016-P-1106 Gordon Johnston Dextrose 5% and Sodium Drug
Regulatory Consultants, Chloride Injection 0.45%
LLC Injection in Plastic Container
FDA-2016-P-1105 Gordon Johnston Dextrose 5% and Sodium Drug
Regulatory Consultants, Chloride Injection 0.3%
LLC Injection in Plastic Container
FDA-2016-P-1104 Gordon Johnston Dextrose 2.5% and Sodium Drug
Regulatory Consultants, Chloride Injection 0.45%
LLC Injection in Plastic Container
FDA-2016-P-1090 Lachman Consultant Naloxone and Opioid Abuse Drug
Services, Inc.

FDA-2016-P-1088 ABHAI LLC Oxybutynin Chloride Drug


Tablets, 2.5 mg

FDA-2016-P-1085 Frontage Laboratories, Acetylcysteine Injection, Drug


Inc. 2GM/10ML and 4GM/20ML
FDA-2016-P-1073 PAR Pharmaceutical Potassium Chloride Oral Drug
Solution

FDA-2016-P-1037 Emprise Pharma Prevacid IV 30 mg/vial Drug

FDA-2016-P-1027 Gland Pharma Limited BENDEKA (Bendamustine HCl Drug


Solution for IV infusion,
100mg/4 mL) Injection
FDA-2016-P-1026 Germaine Laboratories, Aim Tab Reducing Substances/ Medical
Inc. 510(k) Requirements Device

FDA-2016-P-0974 Gordon Johnston SAMSCA (Tolvaptan) Tablets, Drug


Regulatory Consultants, 60 mg
LLC
FDA-2016-P-0770 International Isotopes Xenon XE 133 Gas; Inhalation Drug
Inc. 20mCi/Vial

FDA-2016-P-0769 Empire State Consumer Selenium in PEG 3350 Drugs Drug


Project, Inc.

FDA-2016-A-0746 James T. O'Reilly, Food Grade Salt Derived from Food


University of Cincinnati Radioactive Liquid Waste

FDA-2016-P-0713 Pernix Therapeutics ZOHYDRO ER (hydrocodone Drug


bitartrate) Extended-release
Capsules
FDA-2016-P-0689 Baltimore City Benzodiazepine Black Box Drug
Department of Health, Warning
et al.
FDA-2016-P-0656 Steven Zecola Precision Medicine Initiative Drug

FDA-2016-P-0645 Pharmaceutical Abuse-Deterrent Drugs Drug


Manufacturing
Research Services
FDA-2016-P-0644 Gordon Johnston Olmesartan Medoxomil Tablets, Drug
Regulatory Consultants, 10 mg
LLC
FDA-2016-P-0621 Helsinn Healthcare SA ALOXI (palonosetron HCl) Drug
Injection

FDA-2016-P-0618 Emily Connor Definition of "Spices" on Food Food


Labels

FDA-2016-P-0542 Gordon Johnston Calcium Chloride; Potassium Drug


Regulatory Consultants, Chloride; Sodium Chloride;
LLC Sodium Injection,
20mg/100mL; 30mg/100mL;
600mg/100mL; 310mg/100mL
in Plastic Containers
FDA-2016-P-0541 Gordon Johnston Sodium Chloride Injection Drug
Regulatory Consultants, 0.45% in Plastic Container
LLC
FDA-2016-P-0540 Gordon Johnston Sodium Chloride Injection 3% Drug
Regulatory Consultants, in Plastic Container
LLC
FDA-2016-P-0383 Depomed Inc. NUCYNTA ER (tapentadol) Drug

FDA-2016-P-0378 The Weinberg Group, TRIVARIS (triamcinolone Drug


Inc. acetonide)

FDA-2016-P-0214 Rosalind Advisors, Inc. Extracorporeal Liver Assist Drug


Device Clnical Hold

FDA-2016-P-0187 United Therapeutics TYVASO (treprostinil) Drug


Corporation

FDA-2016-P-0159 Biorex Labs LLC 510(k) Exemption Medical


Device

FDA-2016-P-0147 Bumble Bee Foods, Canned Tuna Food


LLC

FDA-2016-P-0135 Hyman, Phelps & Permethrin Cream, 5% Drug


McNamara, P.C.

FDA-2016-P-0134 Summit Phenylbutazone Powder Animal Drug


Pharmaceuticals, Inc.

FDA-2016-P-0040 Troutman Sanders LLP AMICAR (aminocaproic acid) Drug


Tablets, 1000 mg

FDA-2016-P-0031 Indoco Remedies Furosemide Injection, 10 Drug


Limited mg/mL
Petition Tracker
LAST UPDATED: 2/27/2017

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/28/2016 Pending


(505(q) Certification)

Citizen Petition 12/28/2016 1/23/2017 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition 12/27/2016 Pending

Citizen Petition 12/21/2016 Pending

Citizen Petition 12/9/2016 Pending


(505(q) Certification)

Citizen Petition 12/5/2016 Pending

Citizen Petition - RLD 12/8/2016 Pending


Designation

Citizen Petition 12/6/2016 Pending

Citizen Petition - 12/1/2016 Pending


Listed Drug
Discontinuation
Citizen Petition - 11/22/2016 Pending
ANDA Suitability
Petition
Citizen Petition 11/22/2016 Pending

Citizen Petition - 11/24/2016 Pending


ANDA Suitability
Petition
Citizen Petition 11/24/2016 Pending
(505(q) Certification)
Citizen Petition 11/22/2016 Pending
(505(q) Certification)

Citizen Petition 11/22/2016 Pending


(505(q) Certification)

Citizen Petition 11/17/2016 Pending

Citizen Petition 11/16/2016 11/23/2016 Withdrawn

Citizen Petition 11/17/2016 Pending

Citizen Petition - RLD 11/7/2016 Pending


Designation

Citizen Petition 10/12/2016 2/2/2017 Withdrawn

Citizen Petition 11/1/2016 Pending

Citizen Petition 10/28/2016 Pending

Citizen Petition - RLD 10/27/2016 Pending


Designation

Citizen Petition - 10/26/2016 Pending


Listed Drug
Discontinuation
Citizen Petition - 10/24/2016 Pending
ANDA Suitability
Petition
Citizen Petition 10/21/2016 Pending

Citizen Petition - RLD 10/18/2016 2/22/2017 Withdrawn


Designation

Citizen Petition - RLD 10/19/2016 Pending


Designation

Citizen Petition - 10/19/2016 Pending


ANDA Suitability
Petition
Citizen Petition - 10/172016 Pending
ANADA Suitability
Petition
Citizen Petition - 10/17/2016 1/12/2017 Granted
ANADA Suitability
Petition
Citizen Petition - RLD 10/14/2016 Pending
Designation

Citizen Petition 10/17/2016 Pending


(505(q) Certification)

Citizen Petition 10/13/2016 Pending


(505(q) Certification)

Citizen Petition 10/12/2016 Pending


(505(q) Certification)

Citizen Petition 10/10/2016 1/30/2017 Withdrawn


(505(q) Certification)

Citizen Petition 10/7/2016 Pending

Citizen Petition 10/6/2016 Pending

Citizen Petition - RLD 10/5/2016 1/25/2017 Withdrawn


Designation

Citizen Petition 9/15/2016 1/19/2017 Denied

Citizen Petition - 9/30/2016 Pending


ANDA Suitability
Petition
Citizen Petition 9/30/2016 Pending
(505(q) Certification)

Citizen Petition 9/29/2016 Pending

Citizen Petition 9/29/2016 11/22/2016 Withdrawn

Citizen Petition - 9/27/2016 Pending


ANADA Suitability
Petition
Citizen Petition 9/15/2016 Pending
Citizen Petition 9/16/2016 Pending

Citizen Petition 9/15/2016 2/10/2017 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition 9/15/2016 2/10/2017 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition 9/14/2016 Pending

Citizen Petition 9/14/2016 Pending

Citizen Petition 9/14/2016 Pending

Citizen Petition - RLD 9/12/2016 Pending


Designation

Citizen Petition 8/31/2016 Pending

Citizen Petition - 9/7/2016 Pending


Listed Drug
Discontinuation
Citizen Petition - 8/31/2016 11/8/2016 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 9/9/2016 1/17/2017 Granted
(505(q) Certification)

Citizen Petition 9/7/2016 11/28/2016 Denied


(505(q) Certification)

Citizen Petition - RLD 8/31/2016 Pending


Designation

Citizen Petition 8/25/2016 2/2/2017 Interim Response

Citizen Petition 8/25/2016 2/21/2017 Interim Response

Citizen Petition 8/25/2016 Pending

Citizen Petition 8/25/2016 Pending


Citizen Petition 8/18/2016 1/13/2017 Denied
(505(q) Certification)

Citizen Petition 8/17/2016 Pending

Citizen Petition 8/10/2016 1/5/2017 Denied


(505(q) Certification)

Citizen Petition - 8/3/2016 1/18/2017 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 8/3/2016 Pending

Citizen Petition 7/22/2016 Pending

Citizen Petition 8/1/2016 12/23/2016 Denied


(505(q) Certification)

Citizen Petition - RLD 7/27/2016 1/26/2017 Interim Response


Designation

Citizen Petition - 7/22/2016 Pending


Listed Drug
Discontinuation
Citizen Petition - 7/22/2016 Pending
ANDA Suitability
Petition
Citizen Petition - 7/18/2016 Pending
ANDA Suitability
Petition

Citizen Petition - 7/14/2016 9/2/2016 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 7/12/2016 12/8/2016 Granted in Part;
(505(q) Certification) Denied in Part

Citizen Petition 7/12/2016 Pending

Citizen Petition 7/11/2016 11/8/2016 Denied

Citizen Petition - 7/5/2016 9/26/2016 Granted


ANADA Suitability
Petition
Citizen Petition 7/6/2016 12/22/2016 Interim Response
Citizen Petition 6/30/2016 11/23/2016 Denied

Citizen Petition - 7/5/2016 9/2/2016 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 7/1/2016 11/28/2016 Denied
(505(q) Certification)

Citizen Petition 6/29/2016 7/13/2016 Withdrawn

Citizen Petition 6/29/2016 12/20/2016 Interim Response

Citizen Petition 6/28/2016 11/23/2016 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition 6/22/2016 12/13/2016 Interim Response

Citizen Petition 6/27/2016 Pending

Citizen Petition - 6/24/2016 12/15/2016 Interim Response


Listed Drug
Discontinuation
Citizen Petition - 6/20/2016 12/13/2016 Interim Response
Listed Drug
Discontinuation
Citizen Petition - 6/16/2016 12/13/2016 Interim Response
Listed Drug
Discontinuation
Citizen Petition 6/15/2016 Pending

Citizen Petition - 6/15/2016 12/6/2016 Interim Response


Listed Drug
Discontinuation
Citizen Petition 6/14/2016 12/9/2016 Interim Response

Citizen Petition - RLD 6/8/2016 12/2/2016 Granted


Designation

Citizen Petition 5/31/2016 7/19/2016 Denied


(505(q) Certification)

Citizen Petition 5/31/2016 11/17/2016 Interim Response


Citizen Petition - 5/25/2016 Pending
ANDA Suitability
Petition
Citizen Petition - 5/25/2016 12/12/2016 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 5/23/2016 Pending
ANDA Suitability
Petition
Citizen Petition 5/9/2016 Pending

Citizen Petition 5/17/2016 Pending

Citizen Petition 5/16/2016 11/29/2016 Denied

Citizen Petition - 5/13/2016 Pending


ANDA Suitability
Petition
Citizen Petition - 5/13/2016 Pending
ANDA Suitability
Petition
Citizen Petition - 5/12/2016 Pending
ANDA Suitability
Petition
Citizen Petition - 5/9/2016 Pending
ANDA Suitability
Petition
Citizen Petition - RLD 5/4/2016 11/1/2016 Interim Response
Designation

Citizen Petition 5/5/2016 9/23/2016 Denied

Citizen Petition 5/4/2016 10/31/2016 Interim Response


(505(q) Certification)

Citizen Petition 5/13/2016 Pending

Citizen Petition - 4/27/2016 Pending


ANDA Suitability
Petition
Citizen Petition - 4/27/2016 Pending
ANDA Suitability
Petition
Citizen Petition - 4/27/2016 Pending
ANDA Suitability
Petition
Citizen Petition 4/20/2016 10/19/2016 Interim Response

Citizen Petition 4/19/2016 10/11/2016 Interim Response

Citizen Petition - 4/13/2016 6/10/2016 Denied


ANDA Suitability
Petition
Petition for 7/8/2016 Pending
Reconsideration

Citizen Petition 4/15/2016 Pending


(505(q) Certification)

Citizen Petition 4/15/2016 Pending

Citizen Petition 4/8/2016 9/14/2016 Denied

Citizen Petition 4/6/2016 Pending

Citizen Petition 3/31/2016 9/21/2016 Interim Response

Citizen Petition - RLD 3/30/2016 12/16/2016 Interim Response


Designation

Citizen Petition - RLD 3/30/2016 10/28/2016 Granted


Designation

Citizen Petition - RLD 3/30/2016 12/19/2016 Interim Response


Designation

Citizen Petition - RLD 3/30/2016 10/28/2016 Granted


Designation

Citizen Petition - RLD 3/30/2016 10/28/2016 Granted


Designation

Citizen Petition 3/25/2016 9/21/2016 Interim Response

Citizen Petition - 3/24/2016 Pending


ANDA Suitability
Petition
Citizen Petition - 3/23/2016 Pending
ANDA Suitability
Petition
Citizen Petition 3/23/2016 9/16/2016 Interim Response
(505(q) Certification)

Citizen Petition - 3/18/2016 9/8/2016 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - RLD 3/21/2016 9/15/2016 Granted
Designation

Citizen Petition 3/18/2016 9/6/2016 Denied

Citizen Petition - 3/15/2016 8/2/2016 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - RLD 2/25/2016 8/12/2016 Interim Response
Designation

Citizen Petition 2/14/2016 8/25/2016 Interim Response

Citizen Petition 2/24/2016 Pending


(Advisory Opinion)

Citizen Petition 2/25/2016 7/22/2016 Denied


(505(q) Certification)

Citizen Petition 2/22/2016 8/31/2016 Granted in Part;


Denied in Part

Citizen Petition 2/19/2016 8/2/2016 Interim Response

Citizen Petition 2/22/2016 8/16/2016 Interim Response

Citizen Petition - 2/22/2016 Pending


ANDA Suitability
Petition
Citizen Petition 2/18/2016 5/6/2016 Withdrawn
(505(q) Certification)

Citizen Petition 2/18/2016 5/11/2016 Interim Response

Citizen Petition - RLD 2/10/2016 8/22/2016 Granted


Designation
Citizen Petition - RLD 2/10/2016 8/22/2016 Granted
Designation

Citizen Petition - RLD 2/10/2016 8/22/2016 Granted


Designation

Citizen Petition 1/29/2016 4/29/2016 Denied


(505(q) Certification)

Citizen Petition 1/28/2016 6/2/2016 Not Discontinued for


(505(q) Certification) S/E Reasons

Citizen Petition - 1/16/2016 8/30/2016 Denied


Listed Drug
Discontinuation
Citizen Petition 1/15/2016 6/13/2016 Denied
(505(q) Certification)

Citizen Petition 1/7/2016 6/29/2016 Denied

Citizen Petition 10/9/2015 Pending

Citizen Petition - RLD 1/11/2016 9/27/2016 Withdrawn


Designation

Citizen Petition - 1/12/2016 4/7/2016 Denied


ANADA Suitability
Petition

Citizen Petition - 1/5/2016 Pending


Listed Drug
Discontinuation &
RLD Designation

Citizen Petition - RLD 12/30/2015 6/27/2016 Interim Response


Designation
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2015-A-5109 Wallace, Jordan, Ratliff Effect of FDA import Alerts on Drug


& Brandt, LLC Private Party Contracts

FDA-2015-P-5108 Purdue Pharma L.P. Extended-release Oxycodone Drug

FDA-2015-P-5081 O'Hara, et al. Gluten Content in Medications Drug

FDA-2015-P-5022 PhRMA & BIO Biosimilar Labeling Biologic

FDA-2015-P-4959 Cardinal Health Trientine HCl Capsules, 500 Drug


Regulatory Sciences mg

FDA-2015-P-4946 Zydus Pharmaceuticals ZAROXOLYN (metolazone) Drug


(USA) Inc. Tablets, 5 mg and 10 mg

FDA-2015-P-4945 Ryszard Rokicki Essure Medical


Device

FDA-2015-P-4935 AbbVie Inc. Biosimilar Interchangeability Biologic

FDA-2015-P-4916 REGCON Solutions Ipratropium Bromide; Albuterol Drug


Sulfate Inhalation Solution,
0.083% Base/0.017%
FDA-2015-A-4705 Consorzio del Food Ingredients Listing Food
Formaggio Parmigiano-
Reggiano
FDA-2015-P-4664 Richard Fife Live Turtles & Viable Turtle Other
Eggs

FDA-2015-P-4601 Frier Levitt Compounded Implantable Drug


Testosterone Pellets

FDA-2015-P-4600 Bayer HealthCare LLC MIRENA (Levonorgestrel- Drug


releasing intrauterine system)
FDA-2015-P-4529 UAW Retiree Medical Biosimilar Labeling Drug
Benefits Trust

FDA-2015-P-4582 Margaret Moustafa Safety Information on Statins & Drug


Pulmonary Fibrosis

FDA-2015-P-4566 Concordia LANOXIN (Digoxin) Tablets Drug


Pharmaceuticals

FDA-2015-P-4564 KIND LLC Food Labeling & Dietary Food


Guidelines for Americans

FDA-2015-P-4307 Guy Aliotta Warnings for Xylitol or Other Food


Sugar Alcohols

FDA-2015-P-4237 Gland Pharma Limited Mesna Injection, 20mg/mL (50 Drug


mL IV infusion bag)

FDA-2015-P-4231 REGCON Solutions Phenylephrine HCl Ophthalmic Drug


Solution/Drops 2.5% & 10.0%
(0. 7 mL fill volume)
FDA-2015-P-4224 Flamingo PARAFON FORTE DSC Drug
Pharmaceuticals Ltd. (Chlorzoxazone Tablets,
500mg)

FDA-2015-P-4131 University of Florida Remove Oral Phenylephrine Drug


from the Final OTC Drug
Monograph
FDA-2015-P-4019 Hyman, Phelps & Potassium Chloride for Oral Drug
McNamara, P.C. Solution, 20 mEq

FDA-2015-P-3991 The Take Back America Medical and Recreational Drug


Campaign Marijuana

FDA-2015-P-3980 Teva Pharmaceutical Treanda (bendamustine Drug


Industries, Ltd. hydrochloride)

FDA-2015-P-3959 Daniel F. Kripke, MD Hypnotic Drug Labeling Drug

FDA-2015-P-3942 RegCon Solutions Chlorzoxazone Tablets Drug

FDA-2015-P-3876 World Alliance for FDA Mercury Amalgam Rule Medical


Mercury-Free Dentistry Device

FDA-2015-P-3794 Lawrence R. Savage Certain Medical Procedures Drug

FDA-2015-P-3778 Orthofix, Inc. Universal Device Identification Medical


Device
FDA-2015-P-3739 Bryan Kutz Xylitol when used in peanut/nut Food
butter products

FDA-2015-P-3621 Hospira Inc. VANCOLED (Vancomycin HCl Drug


for Injection)

FDA-2015-P-3540 Lachman Consultant ZAROXOLYN (metolazone) Drug


Services Inc. Tablets, 10 mg

FDA-2015-P-3485 National Chicken Broiler Hatcheries Food


Council, et al.

FDA-2015-P-3410 David K. Cundiff Anticoagulant Drug Drug


Contraindication

FDA-2015-P-3408 David K. Cundiff Anticoagulant Drug Drug


Contraindication

FDA-2015-P-3407 RegCon Solutions, LLC Diazepam Injection 10 mg/2mL Drug


(5mg/mL)

FDA-2015-P-3404 Lupin Pharmaceuticals, LIPTRUSET (ezetimibe and Drug


Inc. atorvastatin) Tablets 10 mg/10
mg, 10 mg/20 mg, 10 mg/40
mg, and 10 mg/80 mg

FDA-2015-P-3400 Lupin Pharmaceuticals, ANTIVERT (Meclizine HCl) Drug


Inc. Tables, 12.5 mg, 25 mg and 50
mg
FDA-2015-P-3391 Ms. Ashley Franz Nivea CoQ10 Cosmetics

FDA-2015-P-3365 Inrange Systems, Inc. Remote Medication Device


Management Systems

FDA-2015-P-3364 Dr. Leroy Hamilton "Return Receipt" Postcards Device

FDA-2015-P-3319 Winifred Begley MEVACOR (lovastatin) Tablets, Drug


20 mg and 40

FDA-2015-P-3299 Clinipace Worldwide THALITONE (chlorthalidone) Drug


Tablets, 15 mg

FDA-2015-P-3139 Kimberly Kideckel Garlic as an Ingredient or Food


Allergen on Food Labels

FDA-2015-P-3108 Ferrosan Medical Collagen-based absorbable Medical


Devices hemostatic devices Device

FDA-2015-P-3107 Ferrosan Medical Collagen-based Absorbable Medical


Devices Hemostatic Devices Device
FDA-2015-P-3085 Mid-Atlantic Rabies Virus - Priority Review Drug
BioTherapeutics, Inc. Voucher

FDA-2015-P-3053 Florek & Endres PLLC IZBA (travoprost) ophthalmic Drug


solution/drops 0.003%

FDA-2015-P-3020 Women's Voices for the Colorants in Feminine Hygiene Cosmetics


Earth Cosmetics

FDA-2015-P-3009 Physicians Committee Partially Hydrogenated Oils Food


for Responsible
Medicine
FDA-2015-P-2962 Regcon Solutions LLC Bromfenac Sodium Ophthalmic Drug
Solution/Drops eq. 0.09% acid

FDA-2015-P-2867 Lachman Consultant Capecitabine Tablets, 300 mg Drug


Services Inc.

FDA-2015-P-2854 Olsson, Frank, Weeda, VenaSeal Closure System Medical


Terman & Matz PC Device

FDA-2015-P-2830 Supernus OXTELLAR XR Drug


Pharmaceuticals (oxcarbazepine) Extended-
release Tablets
FDA-2015-P-2820 Center for Responsible NDA, IND & IDE Requirements Drugs &
Science Medical
Devices
FDA-2015-P-2807 Lachman Consultant Colchicine Capsules, 0.6 mg Drug
Services Inc.

FDA-2015-P-2736 Comodo Health, Inc. Argatroban Injection, 25 mg/25 Drug


mL, 50 mg/50 mL, and 100
mg/100 mL
FDA-2015-P-2678 Marlboro The Ice Diet Food
Gastroenterology PC

FDA-2015-P-2626 US WorldMeds, LLC Drug-Device Combo Products Drug


Containing Apomorphine for
Advanced Parkinson's Disease
FDA-2015-P-2482 Otsuka Pharmaceutical Aripiprazole Lauroxil Drug
Development and
Commercialization, Inc.
FDA-2015-P-2481 SweetSpot Diabetes Diabetes Data Management Medical
Care Software Devices Device

FDA-2015-P-2413 Acura Pharmaceuticals, Abuse-Deterrent Immediate Drug


Inc. Release Oxycodone Tablets

FDA-2015-P-2375 Public Citizen. Seprafilm Bioresorbable Medical


Membrane Device
FDA-2015-P-2374 Hyman, Phelps & Abiraterone Acetate Tablets, Drug
McNamara PC 500mg

FDA-2015-P-2373 David K. Cundiff, MD Anticoagulant Drugs Drug

FDA-2015-P-2344 Lachman Consultant Oxycodone and Drug


Services Inc. Acetaminophen Tablets, 3.75
mg/300 mg and 8.75 mg/300
mg

FDA-2015-P-2247 Tricia Spencer Nutritional Data on Food Food


Labels

FDA-2015-P-2231 Bimeda Inc. Enrofloxacin Chewable Tablets Animal Drug

FDA-2015-P-2230 Hyman, Phelps & Esomeprazole Magnesium Drug


McNamara PC Delayed-Release Tablets, 20
mg (OTC)
FDA-2015-P-2149 Natural Solutions Informed Consent Drug
Foundation

FDA-2015-P-2142 Public Citizen HETLIOZ (tasimelteon) Drug


Capsules

FDA-2015-P-2141 Heritage Pharma Labs Verapamil HCl Tablets, 180 mg Drug


Inc.

FDA-2015-P-2120 Purdue Pharma L.P. Extended-release Oxycodone Drug

FDA-2015-P-2000 AbbVie, Inc. Biosimilars Labeling Biologic

FDA-2015-P-1977 Gerald Steel Fluoridation Chemical Additives Drug


& Fluoridated Drinking Waters

FDA-2015-P-1924 Hunton and Williams Zeltiq CoolSculpting System Medical


LLP Device

FDA-2015-P-1903 Matawan Tretinoin Cream, 0.0435% and Drug


Pharmaceuticals, LLC 0.0625%

FDA-2015-P-1900 CUNY School of Public DEPO PROVERA Drug


Health and Hunter (medroxyprogesterone acetate,
College DMPA) for Injection
FDA-2015-P-1899 Lachman Consultant Fluoxetine HCl Tablets, 60 mg Drug
Services Inc.

FDA-2015-P-1898 Hyman, Phelps & KYTRIL (granisetron HCl) Drug


McNamara, P.C. Tablets, EQ 1 mg and 2 mg
base
FDA-2015-P-1757 Organic and Natural CGMP Requirements Dietary
Health Association Supplement

FDA-2015-P-1752 Wiley Rein LLP ZUBSOLV (buprenorphine and Drug


naloxone sublingual tablets),
Eq. 11.4 mg/ 2.9 mg Base
FDA-2015-P-1722 Helsinn Healthcare SA ALOXI (palonosetron HCl) Drug
Injection

FDA-2015-P-1721 Helsinn Healthcare SA ALOXI (palonosetron HCl) Drug


Injection

FDA-2015-P-1674 Globus Medical Inc. UDI Implementation for Device


Orthopedic Implants

FDA-2015-P-1669 RegCon Solutions Acamprosate Calcium Drug


Delayed-release Tablets

FDA-2015-P-1595 Cubist DIFICID (fidaxomicin) Tablets Drug


Pharmaceuticals, Inc.

FDA-2015-P-1590 Qilu Pharmaceutical Carfilzomib for injection, Drug


Co., Ltd. 10mg/vial and 30mg/vial

FDA-2015-P-1553 3M Drug Delivery Albuterol sulfate metered dose Drug


Systems inhalers

FDA-2015-P-1503 eVenus Pharmaceutical Thiotepa Injection 15mg/vial Drug


Laboratories Inc.

FDA-2015-P-1449 REGCON Solutions Phenylephrine HCl ophthalmic Drug


LLC solution/drops 2.5% and 10%

FDA-2015-P-1433 Michael Welber Genetically Modified Aedes Drug


Aegypti Mosquito

FDA-2015-P-1431 Teva Pharmaceuticals Treanda (bendamustine Drug


hydrochloride)

FDA-2015-P-1404 Physical RESTASIS (cyclosporine) Drug


Pharmaceutica, LLC Ophthalmic Emulsion, 0.05%

FDA-2015-P-1296 Jubilant DraxImage Compounded Drug


Radiopharmaceuticals

FDA-2015-P-1279 Cigar Rights of America Economic quantifier used for Tobacco


defining premium cigars

FDA-2015-P-1218 Hogan Lovells US LLP Visible particulate matter in Drug


parenteral drug products
FDA-2015-P-1201 Tate & Lyle Allulose Food

FDA-2015-P-1197 Stryker Medical Electric Positioning Chai Medical


Device

FDA-2015-P-1187 U.S. Right To Know Use of the term "Diet" as false Food
and misleading

FDA-2015-P-1153 Lachman Consultant Tylenol with Codeine Tablets Drug


Services, Inc. (acetaminophen with codeine
phosphate), 325 mg/7.5 mg,
325 mg/15 mg, 325 mg/30 mg,
and 325 mg/60

FDA-2015-P-1103 Hyman, Phelps & Bumetanide Tablets, 0.5 mg, 1 Drug


McNamara, P.C. mg, and 2 mg

FDA-2015-P-1094 Food and Water Watch Genetically Engineered Food


AquAdvantage Salmon

FDA-2015-P-1090 Baker Hostetler, LLP CORTIFOAM (hydrocortisone Drug


acetate)

FDA-2015-P-1050 Teva Neuroscience Inc. COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2015-P-1004 Lachman Consultant Aspirin and Codeine Drug


Services, Inc. Phosphate Tablets, 325 mg/15
mg, 325 mg/30 mg, 325 mg/45
mg, and 325 mg/60 mg

FDA-2015-P-1003 Lachman Consultant Aspirin and Codeine Drug


Services, Inc. Phosphate Tablets, 300 mg/15
mg, 300 mg/30 mg, 300 mg/45
mg, and 300 mg/60 mg

FDA-2015-P-0989 Organic Pastures Dairy Raw Butter Food


Company

FDA-2015-P-0876 The Escher Fund For 17 Hydroxy-Progesterone Drug


Autism Caproate

FDA-2015-P-0840 Dr. Richard Sherman Phosphorus Content in Drug Drug


Products

FDA-2015-P-0758 Orbicular Bimatoprost Ophthalmic Drug


Pharmaceutical Solution 0.03%
Technologies
FDA-2015-P-0732 Celgene Corporation ABRAXANE (paclitaxel protein- Drug
bound particles for injectable
suspension)
FDA-2015-P-0720 Zydus Pharmaceuticals Methylphenidate HCl Extended Drug
Inc. Release Capsules, 60 mg
FDA-2015-P-0711 Larry Garner Allergen Extracts Drug

FDA-2015-P-0703 Sarah Salem-Robinson Laproscopic Power Medical


Morcellators Device

FDA-2015-P-0633 Dr. Jonathan Smith Drug Labeling - Headaches Drug

FDA-2015-P-0613 Qilu Pharma, Inc. Amikacin Sulfate Injection (EQ Drug


250mgBASE/ML)

FDA-2015-P-0596 Lachman Consultant Olmesartan Medoxomil Tablets, Drug


Services, Inc. 10 mg

FDA-2015-P-0578 Public Citizen’s Health Oral Ketoconazole Drug


Research Group

FDA-2015-P-0569 Koch Parafinczuk & Essure PMA Medical


Wolf, P.A. Device

FDA-2015-P-0547 Gland Pharma Ltd. Ziprasidone Mesylate for Drug


Injection, 10 mg base/vial [10
mg base/0.5 mL] and 40 mg
base/vial [40 mg base/2 mL]

FDA-2015-P-0543 Gland Pharma Ltd. Calcitriol Injection, USP 1 Drug


mcg/mL and 2 mcg/mL

FDA-2015-P-0516 Lachman Consultant Aspirin and Codeine Drug


Services, Inc. Phosphate Tablets, 300 mg/15
mg, 300 mg/30 mg, and 300
mg/60 mg

FDA-2015-P-0464 Colgate Palmolive Anticaries OTC Drug Products Drug


Company Monograph

FDA-2015-P-0403 Lachman Consultant LEVOTHROID (levothyroxine Drug


Services, Inc. sodium) Tablets, 0.025 mg,
0.05 mg, 0.075 mg, 0.088 mg,
0.11 2 mg, 0.125 mg, 0.137
mg, 0.15 mg, 0.175 mg, 0.1
mg, 0.2 mg, and 0.3 mg

FDA-2015-P-0389 Orbicular Bimatoprost Ophthalmic Drug


Pharmaceutical Solution 0.03%
Technologies Pvt Ltd
FDA-2015-P-0335 Chrai Associates, Inc. Gadopentetate Dimeglumine Drug
Injection (15 mL & 20 mL Bulk
Pharmacy Package Vials)
FDA-2015-P-0233 Madison Company Tetrahydrozoline HCl, 0.01 to Cosmetics
0.05% in Consumer Cosmetics
FDA-2015-P-0181 Mylan Specialty, L.P. EpiPen (epinephrine) Auto- Drug
Injector

FDA-2015-P-0095 Leonhard Lang, GmbH Medical Device Tracking Medical


Requirements Exemption Device

FDA-2015-P-0065 Allergan, Inc. RESTASIS (Cyclosporine Drug


Ophthalmic Emulsion) 0.05%

FDA-2015-P-0059 Center For Science In Caffeine Dietary


The Public Interest Supplement

FDA-2015-P-0051 Inrange Systems Inc. Remote Medication Medical


Management System Device

FDA-2015-P-0014 LASIK Consumer Excimer Laser Labeling Medical


Advocates Device
Petition Tracker
LAST UPDATED: 1/18/2017

Petition Type Receipt Date Decision Date Decision

Advisory Opinion 12/22/2015 Pending


Petition

Citizen Petition 12/22/2015 5/20/2016 Denied


(505(q) Certification)

Citizen Petition 12/24/2015 6/21/2016 Interim Response

Citizen Petition 12/22/2015 7/12/2016 Denied


(505(q) Certification)

Citizen Petition - 12/18/2015 Pending


ANDA Suitability
Petition
Citizen Petition - 12/16/2015 5/9/2016 Withdrawn
Listed Drug
Discontinuation
Citizen Petition 12/18/2015 3/14/2016 Interim Response

Citizen Petition 12/16/2015 1/17/2017 Denied


(505(q) Certification)

Citizen Petition - RLD 12/16/2015 12/9/2016 Denied


Designation

Advisory Opinion 12/9/2015 Pending


Petition

Citizen Petition 12/8/2015 5/19/2016 Interim Response

Citizen Petition 12/4/2015 6/17/2016 Interim Response

Citizen Petition 12/4/2015 9/12/2016 Interim Response


(505(q) Certification)
Citizen Petition 11/24/2015 7/12/2016 Denied
(505(q) Certification)

Citizen Petition 11/20/2015 5/18/2016 Interim Response

Citizen Petition 12/1/2015 5/23/2016 Interim Response


(505(q) Certification)

Citizen Petition 12/1/2015 Pending

Citizen Petition 11/16/2015 6/3/2016 Interim Response

Citizen Petition - 11/12/2015 Pending


ANDA Suitability
Petition
Citizen Petition - 11/12/2015 Pending
ANDA Suitability
Petition
Citizen Petition - 11/12/2015 7/14/2016 Not Discontinued for
Listed Drug S/E Reasons;
Discontinuation & Granted
RLD Designation

Citizen Petition 11/6/2015 5/3/2016 Interim Response

Citizen Petition - RLD 10/30/2015 6/28/2016 Granted


Designation

Citizen Petition 10/28/2015 4/13/2016 Interim Response

Citizen Petition 10/26/2015 3/24/2016 Denied


(505(q) Certification)

Citizen Petition 10/26/2015 4/21/2016 Interim Response

Citizen Petition - RLD 10/26/2015 Pending


Designation

Citizen Petition 10/20/2015 4/19/2016 Interim Response

Citizen Petition 9/25/2015 4/7/2016 Interim Response

Citizen Petition 10/16/2015 7/28/2016 Withdrawn


Citizen Petition 10/14/2015 5/20/2016 Interim Response

Citizen Petition - 10/5/2015 12/18/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 10/2/2015 Pending
Listed Drug
Discontinuation
Citizen Petition 9/29/2015 Pending

Citizen Petition 9/25/2015 3/23/2016 Interim Response

Citizen Petition 9/25/2015 3/23/2016 Interim Response

Citizen Petition - RLD 9/24/2015 11/18/2016 Granted


Designation

Citizen Petition - 9/23/2015 11/20/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation

Citizen Petition - 9/21/2015 3/15/2016 Interim Response


Listed Drug
Discontinuation
Citizen Petition 9/16/2015 Pending

Citizen Petition 9/14/2015 Pending

Citizen Petition 9/11/2015 6/21/2016 Interim Response

Citizen Petition - 9/10/2015 1/21/2016 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 9/9/2015 4/26/2016 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 8/26/2015 Pending

Citizen Petition 8/24/2015 Pending

Citizen Petition 8/20/2015 1/21/2016 Interim Response


Citizen Petition 8/18/2015 9/28/2015 Withdrawn

Citizen Petition - 8/20/2015 1/26/2016 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 8/17/2015 Pending

Citizen Petition 8/14/2015 2/10/2016 Interim Response

Citizen Petition - RLD 8/10/2015 Pending


Designation

Citizen Petition - 8/5/2015 Pending


ANDA Suitability
Petition
Citizen Petition 8/3/2015 Pending

Citizen Petition 7/31/2015 12/24/2015 Denied


(505(q) Certification)

Citizen Petition 7/31/2015 3/11/2016 Interim Response

Citizen Petition - RLD 7/30/2015 3/23/2016 Granted


Designation

Citizen Petition - 7/24/2015 Pending


ANDA Suitability
Petition
Citizen Petition 7/24/2015 12/11/2015 Interim Response

Citizen Petition 7/22/2015 1/15/2016 Interim Response

Citizen Petition 7/13/2015 10/5/2015 Denied


(505(q) Certification)

Citizen Petition 7/15/2015 Pending

Citizen Petition 7/7/2015 12/4/2015 Denied


(505(q) Certification)

Citizen Petition 7/7/2015 10/6/2015 Interim Response


Citizen Petition - 7/6/2015 Pending
ANDA Suitability
Petition
Citizen Petition 7/6/2015 Pending

Citizen Petition - 6/30/2015 Pending


ANDA Suitability
Petition

Citizen Petition 6/18/2015 12/11/2015 Interim Response

Citizen Petition - 6/16/2015 8/20/2015 Granted


ANADA Suitability
Petition
Citizen Petition - 6/16/2015 12/1/2015 Withdrawn
ANDA Suitability
Petition
Citizen Petition 6/12/2015 12/8/2015 Denied

Citizen Petition 6/11/2015 12/7/2015 Interim Response

Citizen Petition - RLD 6/10/2015 7/6/2016 Withdrawn


Designation

Citizen Petition 6/10/2015 11/6/2015 Denied


(505(q) Certification)

Citizen Petition 6/2/2015 7/12/2016 Denied


(505(q) Certification)

Citizen Petition 6/1/2015 11/23/2015 Interim Response

Citizen Petition - 5/28/2015 3/14/2016 Denied


Listed Drug
Discontinuation
Citizen Petition - 5/28/2015 Pending
ANDA Suitability
Petition
Citizen Petition 5/27/2015 11/23/2015 Interim Response

Citizen Petition - RLD 5/27/2015 3/24/2016 Granted


Designation

Citizen Petition - 5/27/2015 12/28/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 5/15/2015 Pending

Citizen Petition - 5/15/2015 12/17/2015 Withdrawn


Listed Drug
Discontinuation
Citizen Petition 5/13/2015 10/9/2015 Denied
(505(q) Certification)

Citizen Petition 5/13/2015 10/9/2015 Denied


(505(q) Certification)

Citizen Petition 5/8/2015 11/13/2015 Interim Response

Citizen Petition - RLD 5/8/2015 4/12/2016 Granted


Designation

Citizen Petition 5/6/2015 8/23/2016 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition - 5/6/2015 Pending


ANDA Suitability
Petition
Citizen Petition 5/5/2015 9/16/2015 Denied
(505(q) Certification)

Citizen Petition - RLD 4/30/2015 10/22/2015 Granted


Designation

Citizen Petition - RLD 4/28/2015 10/7/2015 Granted


Designation

Citizen Petition 4/27/2015 8/5/2016 Denied

Citizen Petition 4/27/2015 9/24/2015 Denied


(505(q) Certification)

Citizen Petition 4/24/2015 2/10/2016 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition 4/17/2015 10/14/2015 Interim Response

Citizen Petition 4/16/2015 5/5/2016 Response - Closed

Citizen Petition 4/13/2015 10/2/2015 Interim Response


Citizen Petition 4/10/2015 10/9/2015 Interim Response

Citizen Petition 4/10/2015 Pending

Citizen Petition 4/9/2015 9/22/2015 Interim Response

Citizen Petition - 4/8/2015 11/25/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation

Citizen Petition - RLD 4/3/2015 11/6/2015 Withdrawn


Designation

Citizen Petition 4/2/2015 11/19/2015 Denied

Citizen Petition 4/1/2015 9/25/2015 Interim Response

Citizen Petition 4/1/2015 4/16/2015 Denied


(505(q) Certification)

Citizen Petition - 3/27/2015 Pending


ANDA Suitability
Petition

Citizen Petition - 3/27/2015 Pending


ANDA Suitability
Petition

Citizen Petition 3/27/2015 Pending

Citizen Petition 3/19/2015 9/2/2015 Interim Response

Citizen Petition 3/17/2015 9/11/2015 Interim Response

Citizen Petition - RLD 3/10/2015 4/21/2015 Withdrawn


Designation

Citizen Petition 3/9/2015 8/26/2015 Interim Response


(505(q) Certification)

Citizen Petition - RLD 3/4/2015 8/28/2015 Granted


Designation
Citizen Petition 3/5/2015 12/22/2015 Granted in Part;
Denied in Part

Citizen Petition 3/5/2015 Pending

Citizen Petition 2/27/2015 8/24/2015 Interim Response

Citizen Petition - RLD 2/25/2015 5/16/2016 Granted in Part;


Designation Denied in Part

Citizen Petition - 2/25/2015 Pending


ANDA Suitability
Petition
Citizen Petition 2/24/2015 1/12/2016 Interim Response

Citizen Petition 2/20/2015 Pending

Citizen Petition - 2/19/2015 Pending


ANDA Suitability
Petition

Citizen Petition - RLD 2/19/2015 8/19/2015 Interim Response


Designation

Citizen Petition - 2/18/2015 2/25/2015 Withdrawn


ANDA Suitability
Petition

Citizen Petition 2/11/2015 2/2/2016 Interim Response

Citizen Petition - 2/5/2015 5/27/2016 Granted


Listed Drug
Discontinuation &
RLD Designation

Citizen Petition - RLD 2/4/2015 4/21/2015 Withdrawn


Designation

Citizen Petition - 1/30/2015 Pending


ANDA Suitability
Petition
Citizen Petition 1/22/2015 7/9/2015 Interim Response
Citizen Petition 1/16/2015 6/15/2015 Denied
(505(q) Certification)

Citizen Petition 1/9/2015 Pending

Citizen Petition 12/23/2014 2/10/2016 Granted in Part;


(505(q) Certification) Denied in Part

Citizen Petition 1/7/2015 6/10/2015 Interim Response

Citizen Petition 1/5/2015 Pending

Citizen Petition 1/3/2015 Pending


FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2014-P-2301 Probiomed S.A. de C.V. PROBIOGLA-r (glatiramer Drug


Mexico acetate injection)

FDA-2014-P-2276 Alan Laboratories, Inc. SANCTURA (trospium chloride) Drug


XR 60 mg Capsules, 20 mg
Tablet
FDA-2014-P-2243 Apotex Inc. Atropine Sulfate Ophthalmic Drug
Solution, 1%

FDA-2014-P-2193 Acorda Therapeutics AMPYRA (dalfampridine) Drug


Tablets

FDA-2014-P-2188 Acura Pharmaceuticals Abuse-Deterrent Immediate Drug


Inc. Release Oxycodone Tablets

FDA-2014-P-2169 Lachman Consultant Aspirin 300 mg, Butalbital 50 Drug


Services, Inc. mg and Caffeine 40 mg
Capsules
FDA-2014-P-2168 Lachman Consultant Aspirin 300 mg, Butalbital 50 Drug
Services, Inc. mg and Caffeine 40 mg and
Codeine Phosphate 30 mg
Capsules

FDA-2014-P-2142 Zydus Pharmaceuticals Atropine Sulfate Injection USP, Drug


(USA) Inc. 0.4 mg/mL, 20 mL multiple-
dose vial
FDA-2014-P-2140 Lachman Consultant Thiotepa for Injection 100 Drug
Services, Inc mg/vial

FDA-2014-P-2058 Lachman Consultant BuprenorphineHCl and Drug


Services, Inc Naloxone HCl Sublingual Film
16mg/4mg
FDA-2014-P-2035 Dr. Carla M. Davis Sesame Based Ingredient Food
Labeling

FDA-2014-P-1975 e5 Pharma, LLC Clomipramine HCl Chewable Animal Drug


Tablets
FDA-2014-P-1930 Apotex Inc. ACTICLATE (doxycyline Drug
Hyclate, 150mg Base)

FDA-2014-P-1896 TechReg Services Inc. Oxytocin in Dextrose 5% Drug


Injection (5, 10, and 20 units)

FDA-2014-P-1883 Lannett Holdings Inc. LEVATOL (penbutolol sulfate) Drug


Tablets

FDA-2014-P-1882 Isabella Guajardo Folic acid fortification in Latino Food


staple foods

FDA-2014-P-1844 Lachman Consultant Chlorpromazine HCl Tablets, Drug


Services, Inc. 100 mg

FDA-2014-P-1802 e5 Pharma, LLC Methimazole Oral Solution Animal Drug

FDA-2014-P-1796 Omthera EPANOVA (omega-3-carboxylic Drug


Pharmaceuticals, Inc. acids)

FDA-2014-P-1784 Wood Burditt Group Drug Irradiation Drug

FDA-2014-P-1773 Pharmacists Planning Dibutyl-Phthalates & other Drug


Service, Inc. Phthalates

FDA-2014-P-1771 Amgen, Inc. BPCIA Implementation Biologics

FDA-2014-P-1753 Angela Stanton, Ph.D. CIPRO (Ciprofloxacin) Drug

FDA-2014-P-1752 DARA BioSciences, Inc. Tamoxifen Citrate Drug

FDA-2014-P-1694 Parnell Corporate Carprofen Injection, 50 mg/mL Animal Drug


Services US Inc.

FDA-2014-P-1685 Larry R. Pilot OTC Oral Contraceptives Drug

FDA-2014-P-1673 Tia Gonnella High Level Disinfectant Drug

FDA-2014-P-1670 Gordon Johnston Atropine Sulfate Injection USP, Drug


Regulatory Consultants 0.4 mg/ml, 20 ml multiple-dose
LLC vial
FDA-2014-P-1660 Teva Respiratory LLC QVAR (beclomethasone Drug
dipropriate HFA) Inhalation
Aerosol
FDA-2014-P-1657 Gordon Johnston K-TAB (Potassium Chloride Drug
Regulatory Consultants Extended-releaseTablets), 20
LLC mEq
FDA-2014-P-1656 Alaska Seafood Golden King Crab Food
Marketing Institute and
the Golden King Crab
Coalition
FDA-2014-P-1650 Consumers Union Use of "Natural" Label on Food Food

FDA-2014-P-1649 Spectrum FUSILEV (levoleucovorin) for Drug


Pharmaceuticals Inc. Injection

FDA-2014-P-1622 Genesee Health Clozapine REMS Drug


System

FDA-2014-P-1615 Spectrum FUSILEV (levoleucovorin) for Drug


Pharmaceuticals Inc. Injection

FDA-2014-P-1611 Southern Network on LEVAQUIN (levofloxacin) Drug


Adverse Reactions

FDA-2014-P-1603 Zydus Pharmaceuticals Voriconazole Injection, 10 Drug


USA Inc. mg/mL; 20 mL

FDA-2014-P-1593 Ferring PREPOPIK (citric acid; Drug


Pharmaceuticals, Inc. magnesium oxide; sodium
picosulfate) oral solution
FDA-2014-P-1576 Gordon Johnston Sulfacetamide Sodium Drug
Regulatory Consultants Ophthalmic Solution, 10%
LLC
FDA-2014-P-1570 Natural Solutions Nano Silver - Ebola Dietary
Foundation Supplement

FDA-2014-P-1569 Pharmacists Planning VIAGRA (Sildenafil Citrate) Drug


Service Inc. BTC Status

FDA-2014-P-1562 Institute for Safe CHANTIX (varenicline) Tablets Drug


Medication Practices

FDA-2014-P-1483 Upsher-Smith NAMENDA (memantine HCl) Drug


Laboratories Inc. Tablets, 5 mg & 10 mg

FDA-2014-P-1472 Strides Arcolab Limited, NAMENDA (memantine HCl) Drug


India Tablets, 5 mg & 10 mg
FDA-2014-P-1470 Hyman, Phelps & Thiotepa for Injection, 15 Drug
McNamara, P.C. mg/vial

FDA-2014-P-1429 Oliver Boudreaux Natamycin GRAS Status Food

FDA-2014-P-1383 Lachman Consultant Buprenorphine HCl & Naloxone Drug


Services, Inc. HCl Sublingual Tablets, 4 mg/1
mg and 12 mg/3 mg
FDA-2014-P-1354 Otsuka Aripiprazole Lauroxil Drug
Pharmaceuticals
Company Inc.
FDA-2014-P-1353 International Formula Infant Formula Food
Council

FDA-2014-P-1343 American Society of Epidural Corticosteroid Drug


Interventional Pain Injection Drug Safety
Physicians Communication
FDA-2014-P-1302 Duchesnay Inc. DICLEGIS (doxylamine Drug
succinate and pyridoxine HCl)
Delayed-release Tablets
FDA-2014-P-1293 Hyman, Phelps & HyQvia (Immune Globulin Biologics
McNamara, P.C. Infusion 10% (Human) with
Recombinant Human
Hyaluronidase)
FDA-2014-P-1282 Morgan Lewis & Isotretinoin Capsules, 15 mg, Drug
Bockius LLP 25 mg, and 35 mg

FDA-2014-P-1281 Arnell Golden Gregory Ophthalmic Mitomycin-c Drug


LLP (Compounding)

FDA-2014-P-1269 Pfizer Inc. QUILLIVANT XR Drug


(methylphenidate HCl)
Extended-release Oral
Suspension

FDA-2014-P-1256 Public Citizen OTC Benzocaine Drug Drug


Products

FDA-2014-P-1258 SolRX Global, Inc. OTC Sunscreen Drug Products Drug

FDA-2014-P-1102 Lachman Consultant LOESTRIN FE 1/20 (ethinyl Drug


Services, Inc. estradiol ;norethindrone
acetate) Tablets, 0.02 mg/1 mg

FDA-2014-P-1101 Lachman Consultant LOESTRIN 21 1/20 (ethinyl Drug


Services, Inc. estradiol;norethindrone
acetate) Tablets, 0.02 mg/1 mg
FDA-2014-P-1065 Zydus Pharmaceuticals DUAC (clindamycin phosphate Drug
Inc. and benzoyl peroxide) Gel

FDA-2014-P-1057 Pharmacists Planning CHANTIX (varenicline) Tablets Drug


Service Inc

FDA-2014-P-1044 Zydus Pharmaceuticals Mercaptopurine Tablets Drug


Inc.

FDA-2014-P-1038 Lachman Consultant Amphetamine Sulfate Tablets, Drug


Services, Inc. 2.5 mg, 15 mg, 20 mg, and 30
mg
FDA-2014-P-0984 Lachman Consultant Bisoprolol Fumarate and Drug
Services, Inc. Hydrochlorothiazide Tablets, 5
mgl12.5 mg, and 10 mg/12.5
mg

FDA-2014-P-0980 Lachman Consultant REYATAZ (atazanavir sulfate) Drug


Services, Inc. Capsules, 100 mg

FDA-2014-P-0979 Emcure DIAMOX (acetazolamide) Drug


Pharmaceuticals USA Injection, 500mg base/vial
Inc.
FDA-2014-P-0935 The Juice Products Coconut Water Food
Association

FDA-2014-P-0933 Teva Neuroscience Inc. COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2014-P-0919 Daniel Schumaier, Hearing Aid Devices and Medical


Ph.D. Personal Sound Amplification Device
Products
FDA-2014-P-0916 Hope Pharmaceuticals Sodium Nitrite & Sodium Drug
Thiosulfate Drugs

FDA-2014-P-0908 Mothers Against Dental Amalgum Medical


Mercury Device

FDA-2014-P-0907 Mothers Against Dental Amalgum Medical


Mercury Device

FDA-2014-P-0878 Amarin Pharma Inc. VASCEPA (icosapent ethyl) Drug


Capsules

FDA-2014-P-0862 Alliance for Natural Ban the use of Phthalates in all Drug
Health USA Rx and OTC Drugs

FDA-2014-P-0861 Clinipace Worldwide FOSAMAX (alendronate Drug


sodium)
FDA-2014-P-0856 Southern Network on LEVAQUIN (levofloxacin) Drug
Adverse Reactions

FDA-2014-P-0831 Orthofix Inc. Instruments in the control of Medical


third parties Device

FDA-2014-P-0830 Merz North America CUVPOSA (glycopyrrolate) Drug


Oral Solution - Pediatric
Exclusivity
FDA-2014-P-0825 Orthofix Inc. Implants in the control of third Medical
parties Device

FDA-2014-P-0823 Richard D. Burk Baking Soda Drug

FDA-2014-P-0814 Center for Responsible Clinical Trial Informed Consent Drug


Science

FDA-2014-P-0813 Lachman Consultant Argatroban Injection, lmg/mL, Drug


Services, Inc. in a 50 mg/mL strength

FDA-2014-P-0802 Moon T. Kwon Personal Sound Amplification Medical


Products Device

FDA-1975-N-0012 American Cleaning Food Handler Antiseptic Drug


Institute and Personal Handwash OTC Drug Products
Care Products Council
FDA-2014-P-0794 E5 Pharma LLC Methimazole Film-Coated Drug
Tablets, 2.5mg and 5 mg

FDA-2014-P-0773 Pharmacists Planning Dibutyl-Phthalates and other Drug


Service, Inc. Phthalates

FDA-2014-P-0772 Piedmont Animal Health Pimobendan Soft Chewable Drug


Tablet

FDA-2014-P-0771 Hope Pharmaceuticals Sodium Nitrite & Sodium Drug


Thiosulfate Drugs

FDA-2014-P-0752 Pharmacists Planning Oral & Nasal Naloxone BTC Drug


Service, Inc. Status

FDA-2014-P-0748 Piedmont Animal Health INTERCEPTOR (milbemycin Animal Drug


oxime) FLAVOR TABS

FDA-2014-P-0737 Pfizer Inc. DUAVEE (conjugated Drug


estrogens/bazedoxifene)
FDA-2014-P-0724 Rocky Mountain Exemption Medical
Anaplastology, Inc. Device

FDA-2014-P-0700 Qilu Pharma, Inc. Ceftaroline Fosamil for Drug


Injection, 200 mg/vial and 300
mg/vial
FDA-2014-P-0699 Jason Williams LOVAZA (omega-3-acid ethyl Drug
esters) Capsules

FDA-2014-P-0687 Margaret A. Moline Import alerts #80-06 and #89- Medical


08 Device

FDA-2014-P-0654 Edwards Lifesciences SAPIEN XT THV - QSR Medical


LLC Variance (Certificate to Foreign Device
Government)
FDA-2014-P-0648 InovoBiologic PolyGiycopleX as a New Food
Dietary Ingredient

FDA-2014-P-0647 Kamat Pharmatech Metoprolol Tartrate Oral Drug


Solution (10 mg/mL)

FDA-2014-P-0646 Kamat Pharmatech Trazodone Hydrochloride Oral Drug


Solution (10 mg/mL)

FDA-2014-P-0637 Lachman Consultant FUSILEV (levoleucovorin Drug


Services Inc. calcium) Injection, 175 mg/17.5
mL
FDA-2014-P-0628 Shauce Company Use of "Healthy" on Hot Food
Sauces

FDA-2014-P-0603 Pacific Link Consulting Diazepam Nasal Spray Drug

FDA-2014-P-0594 Hyman, Phelps & Ranbaxy Laboratories, Ltd. Drug


McNamara, P.C. 180-Day Exclusivity

FDA-2014-P-0585 Capstone Law APC Welch's 100% Grape Juice Food


Heart-Health

FDA-2014-P-0549 Emcure SULAR (nisoldipine) Extended- Drug


Pharmaceuticals USA, release Tablets, 25.5 mg
Inc.
FDA-2014-P-0534 Neurelis Inc. Diazepam Nasal Spray Drug

FDA-2014-P-0513 University of TX MD Choline C 11 Injection Drug


Anderson Cancer
Center
FDA-2014-P-0511 Agila Specialties Inc. Baclofen Injection, 50 mcg/mL, Drug
500mcg/mL, 1000mcg/mL and
2000mcg/mL
FDA-2014-P-0497 Ken Surprenant XELODA (capecitabine) Drug

FDA-2014-P-0496 Pharmacists Planning LIPITOR (Atorvastatin Drug


Service Inc. calcium), 10 mg

FDA-2014-P-0462 Wiley Rein LLP Amantadine HCl Capsules, 200 Drug


mg

FDA-2014-P-0461 Wiley Rein LLP Amantadine HCl Capsules, 200 Drug


mg

FDA-2014-P-0446 Starkist Company Sardine Food

FDA-2014-P-0445 Robert L. Lytle Private Membership Misc


Associations

FDA-2014-P-0427 Medicem Technology DILIPAN-S Medical


Device

FDA-2014-P-0422 Jason R. Williams LOVAZA (omega-3-acid ethyl Drug


esters) Capsules

FDA-2014-P-0417 Greenblum & Bernstein, Doxorubicin HCl (Liposomal) Drug


P.L.C. Injection

FDA-2014-P-0407 Almatica Pharma, Inc. NAPRELAN (naproxen Drug


sodium) Extended-release
Tablets
FDA-2014-P-0405 Ken Surprenant Fluorouracil Drug

FDA-2014-P-0404 Teva Respiratory, LLC ProAir HFA (albuterol sulfate) Drug


Inhalation Aerosol

FDA-2014-P-0377 Hyman, Phelps & ACTHAR GEL SYNTHETIC Drug


McNamara, P.C. (seractide acetate) Injection

FDA-2014-P-0367 Hyman, Phelps & Cantharidin Bulk Drug Drug


McNamara, P.C. Substance/Compounding

FDA-2014-P-0328 Hyman, Phelps & K-TAB (potassium chloride Drug


McNamara, P.C. extended release tablets,
USP), 20 meq
FDA-2014-P-0318 Antares Pharma, Inc. OTREXUP (methotrexate) Drug
Injection

FDA-2014-P-0315 Lachman Consultant FUSILEV (levoleucovorin Drug


Services Inc. calcium) Injection, 250 mg/25
mL
FDA-2014-P-0312 Grocery Manufatcurer's Regulation re Labeling Food
Association Products as "Natural"

FDA-2014-P-0311 Sheppard, Mullen, Phenylephrine HCl, USP, 10 Drug


Richter, & Hampton LLP mg/mL, in a 5 mL Glass Vial

FDA-2014-P-0304 Allergan, Inc. RESTASIS (Cyclosporine Drug


Ophthalmic Emulsion) 0.05%

FDA-2014-P-0290 Leroy L. Hamilton Product Code Use Drug

FDA-2014-P-0284 Lachman Consultant Cisplatin Injection 1 mg/mL, in Drug


Services, Inc. strengths of 10 mg/10 mL and
25 mg/25 mL
FDA-2014-P-0283 Leroy L. Hamilton Medical Device Classification Medical
Device

FDA-2014-P-0282 Custo Pharm, Inc. Ceftazidime for Injection, 3 Drug


gram/vial

FDA-2014-P-0263 Ferrero U.S.A., Inc. RACC for Nut Cocoa Based Food
Spreads

FDA-2014-P-0259 Sabra Dipping Co., LLC Hummus Standard of Identity Food

FDA-2014-P-0258 Public Citizen Testosterone Drugs Drug

FDA-2014-P-0251 Gordon Johnston Leucovorin Injection USP Drug


Regulatory Consultants, (preservative free), 50 mg/ 5
LLC mL, 200 mg/20 mL and 350
mg/35 mL

FDA-2014-P-0245 The Sugar Association, "Sugar" in Food and Beverage Food


Inc. Labeling

FDA-2014-P-0241 Public Citizen Testosterone Drugs Drug

FDA-2014-P-0231 Adaptive Engineering Manually Operated Portable Medical


Inc Wheelchair Lifts Device
FDA-2014-P-0230 Lachman Consultant RESCULA (Unoprostone Drug
Services, Inc. Isopropyl) Ophthalmic Solution,
15%
FDA-2014-P-0210 Greenblum & Bernstein, Doxorubicin HCl (Liposomal) Drug
P.L.C. Injection

FDA-2014-P-0209 Horizon Pharma, Inc. VIMOVO Drug


(naproxen/esomeprazole
magnesium) Delayed-release
Tablets

FDA-2014-P-0206 Roger Cady et al. Migraine Drug Labeling Drug

FDA-2014-P-0205 Purdue Pharma LP IR Opioid Analgesics Drug

FDA-2014-P-0196 Lannett Company, Inc. Hydromorphone HCl Tablets, 1 Drug


mg (scored tablets)

FDA-2014-P-0181 Imagenetix, Inc. BLIS K12 Drug/Dietary


Supplement

FDA-2014-P-0169 Strides Inc. THIOPLEX (thioepa) Injection, Drug


15mg/vial

FDA-2014-P-0159 Mead Killion Personal Sound Amplification Medical


Products Device

FDA-2014-P-0158 Christohper Schweitzer Personal Sound Amplification Medical


Products Device

FDA-2014-P-0144 Sucampo Pharma AMITIZA (lubiprostone) Drug


Americas, LLC Capsules

FDA-2014-P-0143 Gail Gudmundsen Personal Sound Amplification Medical


Products Device

FDA-2014-P-0142 Emcure Pantoprazole Sodium for Drug


Pharmaceuticals USA Injection USP
Inc.
FDA-2014-P-0123 Consumer Reports Food Color Additive "Caramel Food
Color"

FDA-2014-P-0117 Allergan, Inc. RESTASIS (Cyclosporine Drug


Ophthalmic Emulsion) 0.05%

FDA-2014-P-0112 NadaChair Product Regulation Medical


Device
FDA-2014-P-0111 LeMaitre Vascular Inc. Reclassification Petition for Medical
Animal Tissue Graft Device

FDA-2014-P-0099 Apotex Corp. NAMENDA XR (Memantine Drug


HCl Extended-Release
Capsules)
FDA-2014-P-0077 Janssen Pharma Biosimilar Naming Biologics
Companies

FDA-2014-P-0076 Lannett Company, Inc. Hydromorphone HCl Oral Drug


Solution, 1 mg per 5 mL

FDA-2014-P-0073 Jubilant Life Sciences Travoprost Ophthalmic Solution Drug


Limited

FDA-2014-P-0038 Riverain Technologies Reclassification Petition for Medical


ClearRead + Detect CADe Device
Device
Petition Tracker
LAST UPDATED: 1/26/2017

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/26/2014 10/5/2015 Denied

Citizen Petition - RLD 12/23/2014 9/12/2016 Granted in part;


Designation Denied in part

Citizen Petition - RLD 12/18/2014 6/5/2015 Granted


Designation

Citizen Petition 12/15/2014 5/14/2015 Denied


(505(q) Certification)

Citizen Petition 12/10/2014 5/8/2015 Denied


(505(q) Certification)

Citizen Petition - 12/10/2014 Pending


ANDA Suitability
Petition
Citizen Petition - 12/10/2014 Pending
ANDA Suitability
Petition

Citizen Petition - 12/8/2014 10/9/2015 Withdrawn


ANDA Suitability
Petition
Citizen Petition - 9/22/2014 Pending
ANDA Suitability
Petition
Citizen Petition - 11/26/2014 Pending
ANDA Suitability
Petition
Citizen Petition 11/25/2014 5/27/2015 Interim response

Citizen Petition - 11/19/2014 1/7/2015 Granted


ANADA Suitability
Petition
Citizen Petition - RLD 11/14/2014 2/3/2015 Withdrawn
Designation

Citizen Petition - 11/12/2014 4/22/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 11/10/2014 1/9/2015 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 11/9/2014 Pending

Citizen Petition - RLD 11/5/2014 5/12/2015 Interim response


Designation

Citizen Petition - 10/31/2014 1/13/2015 Granted


ANADA Suitability
Petition
Citizen Petition 10/31/2014 11/8/2016 Granted
(505(q) Certification)

Citizen Petition 8/15/2014 2/6/2015 Interim response


(505(q) Certification)

Citizen Petition 10/31/2014 10/6/2015 Denied

Citizen Petition 10/29/2014 3/25/2015 Denied


(505(q) Certification)

Citizen Petition 10/28/2014 3/27/2015 Interim response

Citizen Petition 10/28/2014 Pending

Citizen Petition - 9/23/2014 1/7/2015 Denied


ANADA Suitability
Petition
Citizen Petition 9/22/2014 12/28/2016 Denied

Citizen Petition 10/21/2014 12/22/2014 Interim response

Citizen Petition - 9/29/2014 Pending


ANDA Suitability
Petition
Citizen Petition 10/20/2014 5/20/2015 Granted in part;
Denied in part

Citizen Petition - RLD 10/20/2014 11/13/2014 Granted


Designation

Citizen Petition 10/9/2014 Pending

Citizen Petition 10/3/2014 Pending

Citizen Petition 9/30/2014 2/24/2015 Denied


(505(q) Certification)

Citizen Petition 9/10/2014 10/1/2015 Withdrawn

Citizen Petition 10/14/2014 2/24/2015 Denied


(505(q) Certification)

Citizen Petition 9/11/2014 3/9/2015 Interim response

Citizen Petition - 8/5/2014 Pending


ANDA Suitability
Petition
Citizen Petition 9/15/2014 2/12/2015 Denied
(505(q) Certification)

Citizen Petition - RLD 10/9/2014 3/31/2015 Interim response


Designation

Citizen Petition 10/9/2014 Pending

Citizen Petition 10/3/2014 3/31/2015 Denied

Citizen Petition 10/8/2014 12/16/2016 Denied

Citizen Petition - 10/1/2014 3/6/2014 Withdrawn


Listed Drug
Discontinuation
Citizen Petition - 9/29/2014 Pending
Listed Drug
Discontinuation
Citizen Petition - RLD 8/21/2014 7/6/2015 Withdrawn
Designation

Citizen Petition - 9/3/2014 6/22/2015 Denied


ANDA Suitability
Petition
Citizen Petition - 8/29/2014 Pending
ANDA Suitability
Petition
Citizen Petition 9/10/2014 2/3/2015 Denied
(505(q) Certification)

Citizen Petition 9/10/2014 3/9/2015 Denied

Citizen Petition 9/3/2014 10/5/2015 Granted in part;


Denied in part

Citizen Petition 7/11/2014 9/19/2014 Withdrawn


(505(q) Certification)

Citizen Petition 8/20/2014 12/8/2014 Withdrawn

Citizen Petition - 7/18/2014 Pending


ANDA Suitability
Petition
Citizen Petition 7/10/2014 1/8/2015 Interim response

Citizen Petition 8/18/2014 9/14/2015 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 7/28/2014 1/--/2014 Interim response

Citizen Petition 8/13/2014 2/2/2016 Interim response

Citizen Petition - 7/28/2014 1/9/2015 Denied (Moot)


Listed Drug
Discontinuation

Citizen Petition - 7/28/2014 1/9/2015 Denied (Moot)


Listed Drug
Discontinuation
Citizen Petition - RLD 7/9/2014 12/29/2014 Granted
Designation

Citizen Petition 7/23/2014 3/31/2015 Denied

Citizen Petition - RLD 7/22/2014 12/19/2014 Withdrawn


Designation

Citizen Petition - 7/17/2014 Pending


ANDA Suitability
Petition
Citizen Petition - 7/8/2014 Pending
ANDA Suitability
Petition

Citizen Petition - 7/8/2014 1/6/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 7/7/2014 10/28/2014 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 7/2/2014 1/16/2015 Interim response

Citizen Petition 7/2/2014 11/26/2014 Denied


(505(q) Certification)

Citizen Petition 7/1/2014 12/23/2014 Interim response

Citizen Petition 6/18/2014 11/4/2014 Denied


(505(q) Certification)

Citizen Petition 6/30/2014 1/27/2015 Denied

Citizen Petition 6/30/2014 1/27/2015 Denied

Citizen Petition 6/24/2014 11/26/2014 Denied


(505(q) Certification)

Citizen Petition 6/23/2014 12/19/2014 Interim response

Citizen Petition - 6/23/2014 8/14/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 6/23/2014 12/17/2014 Interim response

Citizen Petition 6/20/2014 12/17/2014 Interim response

Citizen Petition 6/19/2014 10/27/2016 Denied


(505(q) Certification)

Citizen Petition 6/19/2014 12/17/2014 Interim response

Citizen Petition 6/18/2014 Pending

Citizen Petition 6/18/2014 12/15/2014 Interim response

Citizen Petition - 6/13/2014 Pending


ANDA Suitability
Petition
Citizen Petition 1/23/2014 7/22/2014 Interim response

Citizen Petition 6/16/2014 Pending

Citizen Petition - 6/12/2014 8/26/2014 Granted


ANADA Suitability
Petition
Citizen Petition 9/8/2014 Pending

Citizen Petition - 6/6/2014 8/26/2014 Granted


ANADA Suitability
Petition
Citizen Petition 6/6/2014 6/19/2014 Withdrawn

Citizen Petition 6/4/2014 3/31/2015 Denied

Citizen Petition - 6/3/2014 8/26/2014 Granted


ANADA Suitability
Petition
Citizen Petition 5/30/2014 10/10/2014 Denied
(505(q) Certification
Citizen Petition 11/3/2014 4/30/2015 Interim response

Citizen Petition - 5/23/2014 Pending


ANDA Suitability
Petition
Citizen Petition 5/22/2014 10/17/2014 Denied

Citizen Petition 10/30/2014 8/17/2016 Denied

Citizen Petition 5/7/2014 Pending

Citizen Petition 5/16/2014 Pending

Citizen Petition - 5/16/2014 Pending


ANDA Suitability
Petition
Citizen Petition - 5/19/2014 Pending
ANDA Suitability
Petition
Citizen Petition - 5/15/2014 8/22/2014 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 5/13/2014 Pending

Citizen Petition 5/7/2014 10/3/2014 Denied


(505(q) Certification

Citizen Petition 5/5/2014 12/23/2015 Withdrawn

Citizen Petition 5/5/2014 10/5/2015 Denied

Citizen Petition - 4/29/2014 8/25/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 4/25/2014 5/7/2014 Withdrawn

Citizen Petition - 4/22/2014 6/30/2015 Granted


ANDA Suitability
Petition
Citizen Petition - RLD 4/21/2014 4/18/2016 Granted in part;
Designation Denied in part

Citizen Petition 4/19/2014 7/29/2016 Granted in part;


Denied in part

Citizen Petition 4/18/2014 3/31/2015 Denied

Citizen Petition - 4/16/2014 Pending


ANDA Suitability
Petition
Citizen Petition - 4/16/2014 Pending
ANDA Suitability
Petition
Citizen Petition 4/11/2014 Pending

Citizen Petition 4/11/2014 11/15/2016 Denied

Citizen Petition - 3/26/2014 Pending


Reclassification

Citizen Petition 4/10/2014 Withdrawn

Citizen Petition 4/8/2014 9/4/2014 Denied

Citizen Petition 4/7/2014 11/25/2015 Denied


(505(q) Certification

Citizen Petition 4/6/2014 7/29/2016 Granted in part;


Denied in part

Citizen Petition 4/4/2014 8/29/2014 Granted in part;


(505(q) Certification Denied in part

Citizen Petition - 4/1/2014 1/23/2017 Discontinued for S/E


Listed Drug Reasons
Discontinuation
Citizen Petition 3/28/2014 Pending

Citizen Petition - RLD 3/19/2014 11/13/2014 Granted


Designation
Citizen Petition 3/18/2014 7/10/2014 Denied
(505(q) Certification)

Citizen Petition - 3/19/2014 8/22/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 3/14/2014 Pending

Citizen Petition - 3/14/2014 Pending


ANDA Suitability
Petition
Citizen Petition 2/28/2014 11/20/2014 Granted in part;
(505(q) Certification) Denied in part

Citizen Petition 3/6/2014 5/16/2014 Denied

Citizen Petition - 3/6/2014 Pending


ANDA Suitability
Petition
Citizen Petition 3/5/2014 5/16/2014 Denied

Citizen Petition - 3/4/2014 Pending


ANDA Suitability
Petition
Citizen Petition 3/4/2014 Pending

Citizen Petition 2/22/2014 9/10/2014 Interim response

Citizen Petition 2/25/2014 7/16/2014 Denied


(505(q) Certification)

Citizen Petition - 2/25/2014 Pending


ANDA Suitability
Petition

Citizen Petition 2/21/2014 1/28/2015 Interim response

Citizen Petition 2/25/2014 2/25/2014 Withdrawn

Citizen Petition 2/14/2014 10/10/2014 Pending


Citizen Petition - RLD 2/12/2014 8/13/2014 Granted
Designation

Citizen Petition 2/11/2014 4/16/2014 Withdrawn

Citizen Petition 2/4/2014 7/3/2014 Denied


(505(q) Certification)

Citizen Petition 2/19/2014 12/14/2015 Denied

Citizen Petition 2/19/2014 Granted in part;


Denied in part

Citizen Petition - 1/9/2014 3/22/2016 Pending


ANDA Suitability
Petition
Citizen Petition 1/31/2014 8/11/2014 Interim response

Citizen Petition - RLD 1/30/2014 2/18/2014 Withdrawn


Designation & Listed
Drug Discontinuation

Citizen Petition 1/30/2014 7/22/2014 Interim response

Citizen Petition 1/30/2014 3/27/2016 Withdrawn

Citizen Petition 1/28/2014 7/17/2015 Denied


(505(q) Certification)

Citizen Petition 1/28/2014 8/5/2014 Interim response

Citizen Petition - 1/23/2014 11/28/2016 Denied


ANDA Suitability
Petition
Citizen Petition 1/23/2014 7/22/2014 Interim response

Citizen Petition 1/15/2014 4/14/2014 Withdrawn

Citizen Petition 1/14/2014 Pending


Citizen Petition 1/23/2014 7/7/2014 Interim response

Citizen Petition 1/13/2014 6/12/2014 Denied


(505(q) Certification)

Citizen Petition 1/13/2014 1/19/2017 Granted in part;


Denied in part

Citizen Petition - 1/9/2014 Pending


ANDA Suitability
Petition
Citizen Petition - RLD 1/8/2014 Pending
Designation

Citizen Petition 12/18/2013 6/17/2014 Interim response


FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2013-P-1711 Morgan Lewis Bockius Hydrocodone Combination Drug


LLP Products Split Scheduling

FDA-2013-P-1710 Noven DAYTRANA (Methylphenidate) Drug


Pharmaceuticals, Inc. Transdermal System

FDA-2013-P-1654 Gordon Johnston Leucovorin Calcium Injection- Drug


Regulatory Consultants, Preservative Free, 10 mg/lmL,
LLC 10 mL total fill volume
FDA-2013-P-1641 Teva Neuroscience COPAXONE (Glatiramer Drug
Acetate) Injection

FDA-2013-P-1640 Hyman, Phelps & OTC Transdermal Nicotine Drug


McNamara, P.C. Patches

FDA-2013-P-1637 Melissa Burdick LEMTRADA (alemtuzumab) Drug

FDA-2013-P-1636 Lannett Company, Inc. Hydromorphone HCl Tablets, 1 Drug


mg (scored tablets) and
Hydromorphone HCl Oral
Solution, 1 mg per 5 mL.

FDA-2013-P-1623 Sigmapharm SAPHRIS (Asenapine Maleate) Drug


Laboratories, LLC Sublingual Tablets

FDA-2013-P-1614 Alliance of African Shea Standards of Identity for Food


Associations Chocolate

FDA-2013-P-1612 EPA Drug Initiative VASCEPA (icosapent ethyl) Drug


Capsules

FDA-2013-P-1611 Clarissa Clarke Tooth Shade Resin Material & Medical


Ultraviolet Activator Special Device
Controls
FDA-2013-P-1609 Lachman Consultant LUPRON DEPOT (leuprolide Drug
Services, Inc. acetate for depot suspension)
Injection
FDA-2013-P-1606 Pharmacists Planning Add drug abuse deterrent Drug
Services, Inc. technology to all hydrocodone
schedule II products
FDA-2013-P-1554 Sigmapharm SAPHRIS (Asenapine Maleate) Drug
Laboratories, LLC Sublingual Tablets

FDA-2013-P-1552 Hearing Industries Reclassification Petition for Medical


Association Wireless Air Conduction Device
Hearing Aids
FDA-2013-P-1516 Spectron mrc, LLC Sodium Pertechnetate Tc-99m Drug
(technetium Tc-99m sodium
pertechnetate)
FDA-2013-P-1515 Lachman Consultant ZOVIRAX (acyclovir sodium) Drug
Services, Inc. for Injection, eq. 1 g base/vial

FDA-2013-P-1512 PetaStrip LLC Ivermectin Soluble Film Animal Drug


(HEARTGUARD Tablets)

FDA-2013-P-1511 PetaStrip LLC Ivermectin Soluble Film Animal Drug


(HEARTGUARD Tablets for
Cats)
FDA-2013-P-1510 Lachman Consultant LUPRON DEPOT-PED Drug
Services, Inc. (leuprolide acetate for depot
suspension), 3.75 mg/vial and
7.5 mg/vial

FDA-2013-P-1509 Dr. S. Albert Edward Common Module 1 * for the Drug


eCTD/RPS

FDA-2013-P-1508 Cadence OFIRMEV (acetaminophen Drug


Pharmaceuticals, Inc. injection)

FDA-2013-P-1507 Dr. S. Albert Edward Uniformly Institute Single Drug


Webtrader Accounts

FDA-2013-P-1505 Teva Respiratory, LLC ProAir HFA (albuterol sulfate) Drug


Inhalation Aerosol

FDA-2013-P-1399 Sigmapharm SAPHRIS (Asenapine Maleate) Drug


Laboratories, LLC Sublingual Tablets

FDA-2013-P-1398 Novartis Group Biosimilar Naming Biologics

FDA-2013-P-1397 UCB, Inc. VIMPAT (lacosamide) Drug

FDA-2013-P-1379 Lachman Consultant PREZISTA (darunavir) Tablets, Drug


Services, Inc. 400 mg
FDA-2013-P-1378 William L. Schwemer Homeopathic Drugs Drug

FDA-2013-P-1377 Covis Pharma Sarl LANOXIN (digoxin) Tablets Drug

FDA-2013-P-1376 Covis Pharma Sarl LANOXIN (digoxin) Tablets Drug

FDA-2013-P-1375 Purdue Pharma L.P. OXYCONTIN (oxycodone HCl) Drug


Extended-release Tablets

FDA-2013-P-1374 Pharmacists Planning Cell Phone Radiation Device


Service, Inc.

FDA-2013-P-1373 Terry L. Tennant QSR Requirements Device

FDA-2013-P-1297 Harmony Cone Ear Ear Candles Device


Candles

FDA-2013-P-1296 Lannett Company, Inc. DIAMOX SEQUELS Drug


(acetazolamide) Extended-
release Capsules
FDA-2013-P-1294 Luitpold INJECTAFER (ferric Drug
Pharmaceuticals Inc. carboxymaltose injection)

FDA-2013-P-1293 United Therapeutics REMODULIN (treprostinil) Drug


Corp. Injection

FDA-2013-P-1292 Sun Pharmaceutical Ganirelix Acetate Injection Drug


Industries, Ltd.

FDA-2013-P-1291 American Herbal FDA Inspections Dietary


Products Association Supplement

FDA-2013-P-1290 G. Pohl-Boskamp NITROLINGUAL PUMPSTRAY Drug


GmbH & Company KG (nitroglycerin lingual spray)

FDA-2013-P-1289 National Advocates for Extended-release and Long- Drug


Pregnant Women acting Opioid Analgesics

FDA-2013-P-1288 National Advocates for Extended-release and Long- Drug


Pregnant Women acting Opioid Analgesics

FDA-2013-P-1287 Aptalis Pharma US, Inc. CANASA (mesalamine) Rectal Drug


Suppositories
FDA-2013-P-1286 Proctor & Gamble OTC Proton Pump Inhibitors Drug
Company

FDA-2013-P-1283 Horizon Pharma, Inc. RAYOS (prednisone) Delayed- Drug


release Tablets

FDA-2013-P-1203 McGuireWoods LLP Ropivacaine HCl Injection Drug


(2mg/mL in a 500mL infusion
bag)
FDA-2013-P-1202 Olsson Frank Weeda Vancomycin Hydrochloride Drug
Terman Matz PC USP, 1.5 grams (base)/vial

FDA-2013-P-1199 CorePharma, LLC SKELAXIN (metaxalone) Drug


Tablets, 400 mg

FDA-2013-P-1153 Generic Pharmaceutical Biosimilar Naming Biologics


Association

FDA-2013-P-1128 Teva Pharmaceutical COPAXONE (Glatiramer Drug


Industries Ltd Acetate) Injection

FDA-2013-P-1127 Tobacco Control Legal Regulation of Non-cigarette Tobacco


Consortium Tobacco Products Products

FDA-2013-P-1126 Lachman Consultant Capecitabine Tablets, 300 mg Drug


Services, Inc. and 1000 mg

FDA-2013-P-1101 Piedmont Animal Health Clindamycin HCl Soft Animal Drug


Chewable Tablets

FDA-2013-P-1082 Horizon Pharma, Inc. RAYOS (prednisone) Delayed- Drug


release Tablets

FDA-2013-P-1080 Reginald Burgess External Prosthetics Medical


Device

FDA-2013-P-1079 Medical Information Manufacturer Communications Drugs and


Working Group About Off-Label Uses Medical
Devices

FDA-2013-P-1078 Parnell Technologies GONABREED (gonadorelin) Animal Drug


Pty Ltd

FDA-2013-P-1061 Navinta LLC Ganciclovir Injection, 500 Drug


mg/10 ml (50mg/mL)
FDA-2013-P-1058 IntelGenx Corp. Rizatriptan Oral Film (MAXALT- Drug
MLT)

FDA-2013-P-1056 Public Citizen Clopidogrel Drug

FDA-2012-E-0196 Sterne, Kessler, Sapien Transcatheter Heart Medical


Goldstein & Fox PLL Valve Device

FDA-2013-P-1055 Actavis Elizabeth LLC SUBUTEX (buprenorphine Drug


HCl) Sublingual Tablets, EQ. 2
mg and 8 mg Base
FDA-2013-P-1002 Zydus Pharmaceuticals Imatinib Mesylate Tablets, 300 Drug
Inc. mg

FDA-2013-P-1001 Weill Cornell Medical OTC drugs products containing Drug


College an ingredient with
anticholinergic or histamine H1
inverse agonist effects

FDA-2013-P-1000 Eclat Pharmaceuticals, Neostigmine Methylsulfate Drug


LLC Injection

FDA-2013-P-0999 Consumer Healthcare Acetaminophen OTC Drug Drug


Products Association Labeling

FDA-2013-P-0998 Millennium VELCADE (bortezomib) for Drug


Pharmaceuticals, Inc. Injection

FDA-2013-P-0997 Thomas J. Quinn Nuclear Magnetic Resonance Medical


Imaging Device

FDA-2013-P-0996 Piedmont Animal Health Cefpodoxime Proxetil Soft Animal Drug


Chewable Tablet

FDA-2013-P-0995 Monosol Rx, Inc. Buprenorphine and Naloxone Drug


Sublingual Film

FDA-2013-P-0990 Corporate Social Use of Metoclopramide in Drug


Responsibility Advocate Force-Feeding at Guantánamo
(Reprieve) Bay
FDA-2013-P-0949 Garrett Skelly C-LEG Medical
Device

FDA-2013-P-0948 Pharmaceutics STAVZOR (valproic acid) Drug


International Delayed-release Capsules
Incorporated
FDA-2013-P-0947 Hyman, Phelps & Cefdinir for Oral Suspension Drug
Mc.Namara, P.C

FDA-2013-P-0946 Lachman Consultant Hydrocodone Bitartrate and Drug


Services, Inc. Acetaminophen Tablets USP,
2.5 mg/300 mg
FDA-2013-P-0945 Lachman Consultant Carisoprodol Tablets, 300 mg Drug
Services, Inc.

FDA-2013-P-0944 Jeffrey G. Thomas DBA DURASEAL Spinal Sealant Medical


Thomas Law Company Device

FDA-2013-P-0886 Arnall Golden Gregory NORPLANT II Levonorgestrel Drug


LLP Implants (JADELLE)

FDA-2013-P-0885 AMAG FERAHEME (ferumoxytol) Drug


Pharmaceuticals, Inc. Injection

FDA-2013-P-0884 Eisai Inc. BELVIQ (lorcaserin HCl) Drug


Tablets and FYCOMPA
(perampanel) Tablets
FDA-2013-P-0862 Spec Pharma, LLC BetaVet (Corticosteroid) Animal Drug

FDA-2013-P-0850 Teva Pharmaceutical ProAir® HFA (albuterol sulfate) Drug


Industries, Ltd. Inhalation Aerosol

FDA-2013-P-0849 Hyman, Phelps & Ampicillin for Injection lg and Drug


Mc.Namara, P.C 2g in ADD-Vantage Vial

FDA-2013-P-0848 Hyman, Phelps & Oxacillin for Injection lg and 2g Drug


Mc.Namara, P.C in ADD-Vantage Vial

FDA-2013-P-0847 Lachman Consultant ZANAFLEX (Tizanidine HCl) Drug


Services, Inc. Tablets

FDA-2013-P-0846 K&L Gates, L.L.P KUVAN (sapropterin Drug


dihydrochloride) Tablets

FDA-2013-P-0830 Lachman Consultant Hydromorphone HCI Drug


Services, Inc. Extended-Release Tablets, 24
mg (EXALGO)
FDA-2013-P-0813 Lachman Consultant Hydrocodone Bitartrate and Drug
Services, Inc. Acetaminophen Tablets, 4
mg/300 mg, 6 mg/300 mg, and
8 mg/300 mg
FDA-2013-P-0800 Lachman Consultant Dapsone Tablets Drug
Services, Inc.
FDA-2013-P-0799 Lachman Consultant GRIS-PEG (griseofulvin Drug
Services, Inc. ultramicrosize) Tablets

FDA-2013-P-0776 Biotechnology Unique Names for Approved Biologics


Information Institute Biological Products

FDA-2013-P-0775 Hyman, Phelps & INVEGA (paliperidone) Drug


McNamara, P.C. Extended-release Tablets

FDA-2013-P-0769 Lachman Consultant Bendamustine Hydrochloride Drug


Services, Inc. for Injection, 200 mg/vial

FDA-2013-P-0768 Salus Pharma LLC ZEFAZONE (cefmetazole Drug


sodium) Injection

FDA-2013-P-0767 Ascend Laboratories, PROGRAF (tacrolimus) Drug


LLC Capsule & Injection

FDA-2013-P-0766 Amedra ALBENZA (albendazole) Drug


Pharmaceuticals LLC Tablets

FDA-2013-P-0761 Poly Cell Technologies Glucagel barley betaglucan Food


LLC fiber

FDA-2013-P-0735 Mario Morais Cerebrospinal Venous Medical


Insufficiency Procedure Device

FDA-2013-P-0711 Allergy & Asthma Rx/OTC Asthma and Drug


Network Mothers of Anaphylaxis Medications
Asthmatics
FDA-2013-P-0703 Center for Lawful Abuse-Deterrent Opioids Drug
Access and Abuse
Deterrence
FDA-2013-P-0701 Organic PasturesDairy Raw Milk/Raw Dairy Products Food
Co. LLC

FDA-2013-P-0695 Steven A. Zecola Metastatic Cancer Drug

FDA-2013-P-0694 Elite Laboratories, Inc Dexbrompheniramine Maleate Drug


and Pseudoephedrine Sulfate
Extended-release Tablets, 6
mg/120 mg
FDA-2013-P-0693 Center for Medicine in TREANDA (bendamustine) for Drug
the Public Interest Injection
FDA-2013-P-0675 Lachman Consultant ULTRACET (tramadol and Drug
Sevices, Inc.n acetaminophen) Tablets, 37.5
mg/325 mg
FDA-2013-P-0671 Lachman Consultant PARAFLEX (chlorzoxazone) Drug
Services, Inc. Tablets

FDA-2013-P-0670 Altaire GENTAK (gentamicin sulfate) Drug


Pharmaceuticals, Inc. Ophthalmic Solution, EQ 0.3%
base
FDA-2013-P-0667 American Clinical Laboratory Developed Tests Medical
Laboratory Association Device

FDA-2013-P-0666 Mutual Pharmaceutical FELDANE (piroxicam) Drug


Company, Inc. Capsules

FDA-2013-P-0665 Arnall Golden Gregory INTAL (cromolyn sodium) Drug


LLP Inhalation Capsule

FDA-2013-P-0664 Watson Laboratories, CRINONE (progesterone gel) Drug


Inc. 4% and 8%

FDA-2013-P-0632 Piedmont Animal Health ANTIROBE (clindamycin HCl) Animal Drug


Capsules

FDA-2013-P-0631 CorePharma, LLC MOBAN (molindone HCL) Drug


Tablets

FDA-2013-P-0615 State of California Hearing Aid Dispensers Medical


Department of Device
Consumer Affairs
FDA-2013-P-0608 Janssen Research and INVEGA SUSTENNA Drug
Development, L.L.C. (paliperidone palmitate)
Extended-release Injectable
Suspension

FDA-2013-P-0574 Watson Laboratories, RAPAFLO (Silodosin) Drug


Inc. Capsules

FDA-2013-P-0573 Lupin Pharmaceuticals, BANZEL (rufinamide) Tablets Drug


Inc.

FDA-2013-P-0572 Prometheus LOTRONEX (alosetron Drug


Laboratories Inc. hydrochloride) Tablets - Shared
REMS

FDA-2013-P-0522 Escher Fund for Autism DICLEGIS (doxylamine Drug


succinate and pyridoxine
hydrochloride) Delayed-release
Tablets
FDA-2013-P-0509 Skadden, Arps, Slate, Immunosuppressants for Drug
Meagher & Flom LLP Maintenance Therapy
Following Renal Transplant

FDA-2013-P-0506 Nomax, Inc. UROCIT-K Powder (potassium Drug


citrate)

FDA-2013-P-0505 Nomax, Inc. Fluorescein Strips Drug

FDA-2013-P-0504 Nomax, Inc. UROCIT-K Powder (potassium Drug


citrate)

FDA-2013-P-0503 Nomax, Inc. UROCIT-K Powder (potassium Drug


citrate)

FDA-2013-P-0493 Altaire AK-FLUOR 25% (fluorescein Drug


Pharmaceuticals, Inc. sodium) Injection

FDA-2013-P-0472 Richard C. Theuer, GRAS Status of Carrageenan Foods


Ph.D.

FDA-2013-P-0471 Bayer HealthCare NATAZIA (estradiol valerate Drug


Pharmaceuticals Inc. and estradiol
valerate/dienogest) Tablets

FDA-2013-P-0470 Salix Pharmaceuticals, APRISO (mesalamine) Drug


Inc. Extended-release Capsules

FDA-2013-P-0435 Tobacco Control Legal Prohibit Menthol as a Tobacco


Consortium, et al Characterizing Flavor in Products
Cigarettes

FDA-2013-P-0426 Shotwell & Carr, Inc. ATOPICA (cyclosporine) Animal Drug

FDA-2013-P-0425 Rhodes Technologies Oxycodone HCl API Drug

FDA-2013-P-0424 Actelion VENTAVIS (iloprost) Inhalation Drug


Pharmaceuticals Ltd. Solution

FDA-2013-P-0408 Chesapeake Regulatory Intraperitoneal Solutions Drug


Group, Inc.

FDA-2013-P-0380 Univ of Florida College Medroxyprogesterone Acetate Drug


of Medicine/UNC
School of Medicine

FDA-2013-P-0371 Auxilium TESTIM (testosterone Drug


Pharmaceuticals, Inc. transdermal gel 1%)
FDA-2013-P-0371 Auxilium TESTIM (testosterone Drug
Pharmaceuticals, Inc. transdermal gel 1%)

FDA-2013-P-0351 Center for Food Safety Antibiotics in Food-Producing Drug


& Institute for Animals
Agriculture and Trade
Policy
FDA-2013-P-0337 Hyman, Phelps & Warning Letter Publication Stay Drug
McNamara, P.C.

FDA-2013-P-0336 Emcure BENADRYL (diphenhydramine Drug


Pharmaceuticals USA HCl) Injection, 50 mg /mL
Inc.

FDA-2013-P-0335 Foley & Lardner LLP NILANDRON (nilutamide) Drug


Tablets

FDA-2013-P-0323 Rapid Precision Testing OTC Sunscreens Drug


Laboratories

FDA-2013-P-0303 Tedor Pharma Inc. METADATE ER Drug


(methylpheindate HCl)
Extended-release Tablets

FDA-2013-P-0299 Trigen Laboratories Bisoprolol Fumarate Tablets Drug


(BioKey, Inc.)

FDA-2013-P-0298 Yale University Metformin Drug

FDA-2013-P-0291 Fukushima Fallout Cesium 134 and Cesium 137 Foods,


Awareness Network contamination Dietary
(Citizens for Health) Supps, and
Drugs
FDA-2013-P-0285 New York City Tobacco Products - Track and Tobacco
Department of Health & Trace System Products
Mental Hygiene, et. al.

FDA-2013-P-0283 Hyman, Phelps & C1 Esterase Inhibitor (Human) Drug


McNamara, P.C. Products (CINRYZE and
BERINERT)

FDA-2013-P-0280 R.J. Reynolds Tobacco Tobacco Products - User Fees Tobacco


Company, et. al. Products

FDA-2013-P-0247 Novartis RECLAST (zoledronic acid) Drug


Pharmaceuticals Corp. Injection
FDA-2013-P-0247 Novartis RECLAST (zoledronic acid) Drug
Pharmaceuticals Corp. Injection

FDA-2013-P-0241 Foley & Lardner LLP CYTOXAN Drug


(cyclophosphamide) for
Injection

FDA-2013-P-0235 Wess Eric Sharpe Lantos Technologies' 3D Ear Medical


Scanner Device

FDA-2013-P-0228 Douglas Barasatian Bleached White Flour GRAS Food


Status

FDA-2013-P-0219 International Isotopes, HICON Kit for the Preparation Drug


Inc. of Sodium Iodide 1131
Capsules and Solution

FDA-2013-P-0217 Center for Science in Added Sugars/High-Fructose Food


the Public Interest Corn Syrup

FDA-2013-P-0203 Merchant & Gould P.C. VFEND IV (voriconazole) for Drug


Injection

FDA-2013-P-0198 Takeda DEXILANT (dexlansoprazole) Drug


Pharmaceuticals delayed-release capsules
U.S.A., Inc.

FDA-2013-P-0204 Square GDUFA User Fees Drug


Pharmaceuticals Ltd
(Chrai Associates, Inc.)

FDA-2013-P-0199 Richard M. Karcich Software Validation Medical


Device

FDA-2013-P-0170 Clinipace Worldwide PLAQUENIL Drug


(hydroxychloroquine sulfate
tablet) 200 mg

FDA-2013-P-0163 Teva Pharmaceutical PARAGARD T 380A Drug


Industries Ltd. Intrauterine Copper
Contraceptive

FDA-2013-P-0148 Crowell & Moring LLP. LOVAZA (omega-3-acid ethyl Drug


esters) Capsules

FDA-2013-P-0127 Santarus, Inc. UCERIS (budesonide) Drug


Extended-release Tablets

FDA-2013-P-0119 Ferring PREPOPIK (citric acid; Drug


Pharmaceuticals, Inc. magnesium oxide; sodium
picosulfate) oral solution
FDA-2013-P-0119 Ferring PREPOPIK (citric acid; Drug
Pharmaceuticals, Inc. magnesium oxide; sodium
picosulfate) oral solution

FDA-2013-P-0113 IGI Laboratories Inc. CORDRAN (flurandrenolide) Drug


Ointment USP, 0.05%

FDA-2013-P-0076 Minnesota Medical 510(k) Process Medical


Device Alliance Device

FDA-2013-P-0070 Ikaria, Inc. 510(k) Clearance of GeNOsy1 Medical


MV-1000 Device

FDA-2013-P-0066 Pharmacists Planning St John's Wort (hypericum Dietary


Services, Inc. perforatum) Supplement

FDA-2013-P-0058 Gilead Sciences, Inc. STRIBILD (elvitegravir, Drug


cobicistat, emtricitabine,
tenofovir disoproxil fumarate)
Tablets

FDA-2013-P-0048 James P Reichmann ZOFRAN (ondansetron) Drug

FDA-2013-P-0047 American Heart Raw fruits & vegetables; Food


Association Single-ingredient or mixtures of
frozen or canned fruits and
vegetables

FDA-2013-P-0040 Lupin Pharmaceuticals, PHOSLO (calcium acetate) Drug


Inc. Capsules

FDA-2013-P-0028 Custo Pharm Inc. Clotrimazole Troche/Lozenge Drug

FDA-2013-P-0027 Custo Pharm Inc. Midodrine HCl Tablets Drug

FDA-2013-P-0025 Teva Pharmaceutical Approval of Multiple Sclerosis Drug


Industries Ltd. Drugs
Petition Tracker
LAST UPDATED: 2/10/2017

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/27/2013 2/11/2014 Denied

Citizen Petition 12/24/2014 5/20/2014 Denied


(505(q) Certification)

Citizen Petition - 12/17/2014 6/16/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 12/5/2013 5/2/2014 Denied
(505(q) Certification)

Citizen Petition 12/5/2013 6/4/2015 Granted in part;


Denied in part

Citizen Petition 12/4/2013 2/4/2015 Granted

Citizen Petition - 12/9/2013 1/7/2014 Withdrawn


ANDA Suitability
Petition

Citizen Petition 12/9/2013 5/8/2014 Denied


(505(q) Certification

Citizen Petition 11/15/2013 8/12/2015 Interim response

Citizen Petition 12/5/2013 6/3/2014 Interim response

Citizen Petition 12/2/2013 3/26/2014 Interim response

Citizen Petition - 11/26/2013 10/8/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 11/26/2013 9/23/2014 Granted in part;
Denied in part

Citizen Petition 11/27/2013 12/7/2013 Withdrawn


(505(q) Certification

Citizen Petition 12/5/2013 3/4/2016 Withdrawn

Citizen Petition - 11/21/2013 6/2/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 11/18/2013 4/11/2014 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 11/7/2013 1/31/2014 Pending
ANADA Suitability
Petition
Citizen Petition - 11/7/2013 1/31/2014 Pending
ANADA Suitability
Petition
Citizen Petition - 11/5/2013 8/20/2014 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation

Citizen Petition 11/4/2013 3/20/2014 Interim response

Citizen Petition 11/4/2013 4/3/2014 Denied


(505(q) Certification

Citizen Petition 10/17/2013 3/20/2014 Interim response

Citizen Petition 11/15/2013 4/10/2014 Granted in part;


(505(q) Certification Denied in part

Citizen Petition 10/31/2013 11/27/2013 Withdrawn


(505(q) Certification

Citizen Petition 10/28/2013 1/19/2017 Denied

Citizen Petition 11/18/2013 4/30/2014 Denied


(505(q) Certification

Citizen Petition - 10/22/2013 4/2/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 10/24/2013 6/5/2014 Interim response

Citizen Petition 10/21/2013 3/20/2014 Interim response

Citizen Petition 10/21/2013 Pending

Citizen Petition 10/22/2013 3/21/2014 Denied


(505(q) Certification

Citizen Petition 10/17/2013 3/7/2014 Interim response

Citizen Petition 10/17/2013 Pending

Citizen Petition 9/30/21013 Pending

Citizen Petition - 10/22/21013 Pending


ANDA Suitability
Petition
Citizen Petition 10/1/21013 3/28/2014 Interim response

Citizen Petition 10/17/21013 3/10/2014 Denied


(505(q) Certification)

Citizen Petition 10/17/21013 2/7/2014 Granted in part;


Denied in part

Citizen Petition 10/18/21013 7/23/2014 Denied

Citizen Petition - 10/7/21013 10/31/2013 Denied


Petition for Stay

Citizen Petition - 10/17/2013 4/16/2014 Denied


Petition for Stay

Citizen Petition 10/17/2013 4/16/2014 Denied

Citizen Petition 10/17/2013 3/12/2014 Denied


(505(q) Certification)
Citizen Petition 10/17/2013 3/28/2014 Denied
(505(q) Certification)

Citizen Petition 10/17/2013 3/12/2014 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition - 9/26/2013 9/19/2016 Granted


ANDA Suitability
Petition
Citizen Petition - 9/27/2013 1/6/2017 Granted
ANDA Suitability
Petition
Citizen Petition - 9/20/2013 4/7/2014 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 9/17/2013 1/19/2017 Denied

Citizen Petition 9/12/2013 1/3/2014 Withdrawn


(505(q) Certification)

Citizen Petition 9/3/2013 3/5/2014 Interim response

Citizen Petition - 9/9/2013 Pending


ANDA Suitability
Petition
Citizen Petition - 5/24/2013 11/19/2013 Granted
ANADA Suitability
Petition
Citizen Petition 9/4/2013 10/4/2013 Withdrawn
(505(q) Certification)

Citizen Petition 8/29/2013 6/2/2014 Denied

Citizen Petition 9/3/2013 6/6/2014 Granted

Petition for Stay and 2/8/2017


Reconsideration

Citizen Petition - 9/3/2013 Pending


ANADA Suitability
Petition
Citizen Petition - 8/29/2013 9/13/2013 Withdrawn
ANDA Suitability
Petition
Citizen Petition 8/22/2013 2/5/2014 Withdrawn

Citizen Petition 8/22/2013 2/18/2014 Interim response

Citizen Petition - PTE 8/21/2013 Pending


Due Diligence

Citizen Petition - 8/20/2013 2/13/2015 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 8/16/2013 Pending
ANDA Suitability
Petition
Citizen Petition 8/16/2013 2/4/2014 Interim response

Citizen Petition 8/15/2013 12/18/2013 Denied

Citizen Petition 8/15/2013 8/1/2016 Interim response

Citizen Petition 8/13/2013 1/10/2014 Denied


(505(q) Certification)

Citizen Petition 8/13/2013 Pending

Citizen Petition - 8/13/2013 12/9/2013 Granted


ANADA Suitability
Petition
Citizen Petition 8/12/2013 9/18/2013 Granted in part;
(505(q) Certification) Denied in part

Citizen Petition 8/12/2013 2/7/2014 Interim response

Citizen Petition 8/9/2013 3/21/2014 Denied

Petition for 4/8/2014 8/28/2014 Interim response


Reconsideration

Citizen Petition - 8/8/2013 2/18/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - RLD 8/5/2013 Pending
Designation

Citizen Petition - 8/5/2013 Pending


ANDA Suitability
Petition
Citizen Petition - 8/5/2013 Pending
ANDA Suitability
Petition
Citizen Petition 8/1/2013 Pending

Citizen Petition - 7/24/2013 8/29/2014 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 7/24/2013 1/13/2014 Interim response
(505(q) Certification)

Citizen Petition 7/25/2013 4/30/2014 Denied

Citizen Petition 7/12/2013 10/28/2014 Denied

Citizen Petition 7/12/2013 12/9/2013 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition - RLD 7/11/2013 12/20/2013 Granted


Designation

Citizen Petition - RLD 7/11/2013 12/20/2013 Granted


Designation

Citizen Petition - 7/11/2013 Pending


ANDA Suitability
Petition
Citizen Petition 7/11/2013 11/17/2014 Denied

Citizen Petition - 7/10/2013 Pending


ANDA Suitability
Petition
Citizen Petition - 7/3/2013 Pending
ANDA Suitability
Petition

Citizen Petition 7/1/2013 Pending


Citizen Petition - 7/1/2013 Pending
ANDA Suitability
Petition
Citizen Petition 6/21/2013 Pending

Citizen Petition - 6/25/2013 11/12/2013 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 6/19/2013 Pending
ANDA Suitability
Petition
Citizen Petition - 6/18/2013 3/11/2014 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition - 6/18/2013 Pending
ANDA Suitability
Petition
Citizen Petition 6/18/2013 2/19/2016 Denied

Citizen Petition - 2/21/2013 Pending


Health Claim Petition

Citizen Petition 6/11/2013 6/19/2014 Granted in part;


Denied in part

Petition for 7/4/2014 1/19/2017 Granted in part;


Reconsideration Denied in part

Citizen Petition 6/13/2013 5/15/2014 Interim response

Citizen Petition 6/11/2013 10/25/2013 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 6/5/2013 11/25/2014 Denied

Citizen Petition 6/6/2013 7/28/2013 Denied

Citizen Petition - RLD 6/6/2013 8/2/2013 Withdrawn


Designation

Citizen Petition 6/7/2013 9/13/2013 Denied


Citizen Petition - 6/5/2013 Pending
ANDA Suitability
Petition
Citizen Petition - 6/5/2013 10/23/2013 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition - RLD 6/5/2013 12/13/2013 Granted
Designation

Citizen Petition 6/4/2013 11/26/2013 Interim response

Citizen Petition - 5/31/2013 6/26/2013 Withdrawn


ANDA Suitability
Petition
Citizen Petition - 6/3/2013 10/24/2013 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 6/4/2013 10/30/2015 Granted in part;
(505(q) Certification) Denied in part

Citizen Petition - 5/24/2013 7/18/2013 Approved


ANADA Suitability
Petition
Citizen Petition - 5/23/2013 11/7/2013 Not Discontinued for
Listed Drug S/E Reasons
Discontinuation
Citizen Petition 6/4/2012 Pending

Citizen Petition 5/9/2013 11/5/2013 Interim response


(505(q) Certification)

Citizen Petition 5/10/2013 10/3/2013 Denied


(505(q) Certification)

Citizen Petition - 5/10/2013 11/21/2013 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation

Citizen Petition 5/10/2013 10/7/2013 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 4/30/2013 10/18/2013 Interim response


Citizen Petition 4/30/2013 7/19/2013 Granted in part;
Denied in part

Citizen Petition - 4/25/2013 Pending


ANDA Suitability
Petition

Citizen Petition - 4/25/2013 6/10/2013 Withdrawn


ANDA Suitability
Petition

Citizen Petition - RLD 4/25/2013 11/7/2014 Denied


Designation

Citizen Petition - 4/25/2013 10/23/2013 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation

Citizen Petition - RLD 4/24/2013 11/1/2013 Granted


Designation

Petition for 4/19/2013 8/1/2014 Withdrawn


Reconsideration

Citizen Petition 4/19/2013 2/21/2014 Denied


(505(q) Certification)

Citizen Petition 4/18/2013 9/12/2013 Denied


(505(q) Certification)

Citizen Petition 4/12/2013 10/7/2013 Interim response

Citizen Petition - 4/22/2013 8/1/2013 Granted


ANADA Suitability
Petition

Citizen Petition 4/10/2013 8/16/2013 Denied


(505(q) Certification)

Citizen Petition 4/8/2013 9/27/2013 Interim response

Citizen Petition - RLD 4/3/2013 11/22/2013 Granted


Designation

Citizen Petition 4/2/2013 7/7/2015 Denied

Citizen Petition 3/26/2013 7/23/2014 Granted in part;


(505(q) Certification) Denied in part
Citizen Petition 3/26/2013
(505(q) Certification)

2/9/2015 Granted in part;


Denied in part

Citizen Petition 3/15/2013 9/4/2013 Interim response

Petition for Stay of 3/19/2013 3/28/2013 Withdrawn


Action

Citizen Petition - 3/18/2013 4/25/2013 Withdrawn


Listed Drug
Discontinuation

Citizen Petition 3/15/2013 6/21/2013 Withdrawn

Citizen Petition 3/18/2013 9/9/2013 Interim response

Citizen Petition - 3/13/2013 7/9/2013 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation

Citizen Petition - RLD 3/13/2013 11/13/2013 Denied


Designation

Citizen Petition 3/12/2013 4/8/2016 Granted in part;


Denied in part

Citizen Petition - 5/4/2016


Petition for
Reconsideration
Citizen Petition 3/12/2013 6/4/2013 Interim response

Citizen Petition 3/11/2013 9/5/2013 Interim response

Citizen Petition 3/8/2013 12/17/2014 Withdrawn

Citizen Petition 3/7/2013 7/10/2013 Granted

Citizen Petition - 3/4/2013 8/1/2013 Denied


(505(q) Certification)
Petition for 8/23/2013 12/4/2013 Denied
Reconsideration

Citizen Petition - 2/27/2013 8/5/2013 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation

Citizen Petition 2/26/2013 Pending

Citizen Petition 2/21/2013 8/15/2013 Interim response

Citizen Petition - 2/21/2013 12/8/2014 Granted


ANDA Suitabiity
Petition

Citizen Petition 2/20/2013 8/14/2013 Interim response

Citizen Petition 2/19/2013 8/13/2013 Interim response

Citizen Petition 2/15/2013 7/11/2013 Denied


(505(q) Certification)

Citizen Petition 2/14/2013 7/12/2013 Denied

Citizen Petition 2/15/2013 Pending

Citizen Petition - 2/12/2013 Pending


ANDA Suitability
Petition

Citizen Petition 2/11/2013 8/8/2013 Interim response

Citizen Petition 2/6/2013 2/21/2014 Denied

Citizen Petition 2/1/2013 12/11/2014 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 1/29/2013 2/21/2014 Denied


Petition for 3/21/2014 10/10/2014 Denied
Reconsideration/Petit
ion for STay (505(q)
Certification)

Citizen Petition - 1/28/2013 6/11/2013 Not Discontinued for


Listed Drug S/E Reasons
Discontinuation
Citizen Petition 1/2/2013 7/25/2013 Denied

Petition for Stay of 1/2/2013 7/25/2013 Denied


Action

Citizen Petition 1/14/2013 9/11/2014 Granted in part;


Denied in part

Citizen Petition 1/9/2013 Pending

Citizen Petition 1/8/2013 2/21/2014 Denied

Petition for 3/24/2014 10/10/2014 Denied


Reconsideration
(505(q) Certification)
Citizen Petition 1/7/2013 10/27/2015 Denied

Citizen Petition - 1/9/2013 Pending


Health Claim Petition

Citizen Petition - 1/3/2013 7/3/2013 Denied


Second RLD
Designation

Citizen Petition - 12/31/2012 1/31/2013 Withdrawn


Second RLD
Designation
Citizen Petition - RLD 12/31/2012 1/31/2013 Withdrawn
Designation

Citizen Petition 12/31/2012 3/27/2013 Denied


(505(q) Certification)
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2012-P-1091 Valeant WELLBUTRIN XL (bupropion Drug


Pharmaceuticals HCl) Extended-release Tablets,
International, Inc. 300 mg
FDA-2012-P-1087 Warner Chilcott ASACOL/ASACOL HD Drug
Company, LLC (mesalamine) Delayed-release
Tablets
FDA-2012-P-1072 Boehringer Ingelheim SPIRIVA HandiHaler Drug
Pharma, Inc. (tiotropium bromide inhalation
powder)

FDA-2012-P-1028 Reckitt Benckiser SUBUTEX (buprenorphine Drug


Pharmaceuticals, Inc. HCl) &
SUBOXONE(buprenorphine
HCl; naloxone HCl)

FDA-2012-P-1018 Mutual Pharmaceutical COLCRYS (colchicine) Tablets Drug


Company, Inc.

FDA-2012-P-1009 Pfizer Inc. OXECTA (oxycodone HCl) Drug


Tablets

FDA-2012-P-0951 Endo Pharmaceuticals, OPANA ER (oxymorphone Drug


Inc. HCI) Extended-release Tablets

FDA-2012-P-0947 Mallinckrodt Inc. EXALGO (Hydromorphone Drug


HCl) Extended-release Tablets

FDA-2012-P-0943 Sunovion LUNESTA (eszopiclone) Drug


Pharmaceuticals, Inc Tablets

FDA-2012-P-0939 Purdue Pharma L.P. OxyContin (oxycodone Drug


hydrochloride) Controlled-
Release Tablets

FDA-2012-P-0932 Noven DAYTRANA (methylphenidate) Drug


Pharmaceuticals, Inc. Transdermal System

FDA-2012-P-0915 Sunovion LUNESTA (eszopiclone) Drug


Pharmaceuticals, Inc Tablets
FDA-2012-P-0895 Endo Pharmaceuticals, OPANA ER (oxymorphone Drug
Inc. HCI) Extended-release Tablets

FDA-2012-P-0779 Valeant ZOVIRAX (acyclovir) Ointment Drug


Pharmaceuticals 5%
International, Inc.

FDA-2012-P-0764 The Joseph Dedvukaj QSYMIA (phentermine and Drug


Firm, P.C. topiramate extended-release)
Capsules

FDA-2012-P-0760 Purdue Pharma L.P. OxyContin (oxycodone Drug


hydrochloride) Controlled-
Release Tablets

FDA-2012-P-0749 Merck Sharp & Dohme NASONEX (mometasone Drug


Corp. furoate monohyrdrate)

FDA-2012-P-0733 Jazz Pharmaceuticals, XYREM (sodium oxybate) Oral Drug


Inc. Solution

FDA-2012-P-0647 Laboratorios SALVAT CETRAXAL (ciprofloxacin HCl) Drug


SA

FDA-2012-P-0637 KV Pharmaceutical Hydroxyprogesterone Caproate Drug


Company Injection

FDA-2012-P-0607 AIDS Healthcare TRUVADA (emtricitabine and Drug


Foundation tenofovir disoproxil fumarate)

FDA-2012-P-0583 Pfizer, Inc. LYRICA (pregabalin) Drug

FDA-2012-P-0555 Teva Neuroscience COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2012-P-0549 Anatase ROCALTROL (calcitriol) Drug


Biopharmaceutic Capsules, 0.25 microgram and
Consulting LLC 0.5 microgram

FDA-2012-P-0545 Pfizer, Inc. LYRICA (pregabalin) Drug

FDA-2012-P-0515 Osmotica Venlafaxine HCl Extended- Drug


Pharmaceutical Corp. Release Tablets

FDA-2012-P-0507 Cumberland ACETADOTE (acetyl cysteine Drug


Pharmaceuticals Inc. injection)

FDA-2012-P-0499 Jazz Pharmaceuticals, XYREM (sodium oxybate) Oral Drug


Inc. Solution
FDA-2012-P-0412 Anatase ROCALTROL (calcitriol) Drug
Biopharmaceutic Capsules, 0.25 microgram and
Consulting LLC 0.5 microgram

FDA-2012-P-0295 Janssen ELMIRON (pentosan Drug


Pharmaceuticals, Inc. polysulfate sodium)

FDA-2012-P-0189 Lannett Company, Inc. Ocycodone HCl and Cocaine Drug


and Cody Laboratories, HCl (Grandfather status)
Inc.

FDA-2012-P-0184 Fresenius Medical Care PhosLo (calcium acetate) Drug


North America

FDA-2012-P-0053 Lannett Company, Inc. Morphine Sulfate (Grandfather Drug


and Cody Laboratories, status)
Inc.
Petition Tracker
LAST UPDATED: 12/16/2016

Petition Type Receipt Date Decision Date Decision

Citizen Petition 10/31/2012 3/29/2013 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 10/24/2012 3/22/2013 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 10/17/2012 4/15/2013 Interim response;


(505(q) Certification) FDA does not
consider this a 505(q)
petition
Citizen Petition 9/25/2012 2/22/2013 Denied
(505(q) Certification)

Citizen Petition 9/21/2012 2/15/2013 Denied


(505(q) Certification)

Citizen Petition 9/21/2012 2/15/2013 Denied


(505(q) Certification)

Citizen Petition 8/31/2012 1/23/20123 Denied


(505(q) Certification)

Citizen Petition 8/31/2012 1/25/2013 Denied


(505(q) Certification)

Citizen Petition 8/29/2012 1/23/2013 Denied


(505(q) Certification)

Citizen Petition 8/29/2012 1/23/2013 Denied


(505(q) Certification)

Petition for 2/22/2013 3/21/2014 Denied


Reconsideration

Citizen Petition 8/27/2012 1/23/2013 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 8/16/2012 8/30/2012 Withdrawn


(505(q) Certification) (resubmitted as FDA-
2012-P-0943)
Citizen Petition 8/13/2012 2/8/2013 Interim response;
(505(q) Certification) FDA does not
Listed Drug consider this a 505(q)
Discontinuation petition

5/10/2013 Denied

Citizen Petition 7/18/2012 12/14/2012 Denied


(505(q) Certification)

Citizen Petition 7/17/2012 12/14/2012 Denied


(505(q) Certification)

Citizen Petition 7/16/2012 10/3/2012 Closed (resubmitted


(505(q) Certification) as FDA-2012-P-
0939)

Citizen Petition 7/12/2012 12/7/2012 Denied


(505(q) Certification)

Citizen Petition 7/10/2012 12/13/2012 Denied


(505(q) Certification)

Citizen Petition 6/19/2012 11/16/2012 Granted


(505(q) Certification)

Citizen Petition 6/15/2012 1/2/2013 Denied


(505(q) Certification)

Citizen Petition 6/8/2012 7/16/2012 Denied (Not


(505(q) Certification) considered a 505(q)
petition)

Citizen Petition 6/6/2012 11/30/2012 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 6/4/2012 11/30/2012 Denied


(505(q) Certification)

Citizen Petition 5/31/2012 11/27/2012 Denied


(505(q) Certification)

Citizen Petition 5/31/2012 6/6/2012 Withdrawn


(505(q) Certification) (Resubmitted as
FDA-2012-P-0583)

Citizen Petition 5/22/2012 11/16/2012 Denied


(505(q) Certification)

Citizen Petition 5/18/2012 11/7/2012 Denied


(505(q) Certification)

Citizen Petition 5/18/2012 11/13/2012 Denied


(505(q) Certification)
Citizen Petition 4/25/2012 5/31/2012 Withdrawn
(505(q) Certification) (Resubmitted as
FDA-2012-P-0549)

Citizen Petition 3/26/2012 9/26/2012 Withdrawn


(505(q) Certification)

Citizen Petition 2/24/2012 7/5/2012 Denied (Ocycodone


(505(q) Certification) HCl)

11/12/2015 Denied (Cocaine


HCl)

Citizen Petition 2/22/2012 8/9/2012 Denied


(505(q) Certification)

Citizen Petition 1/12/2012 12/9/2016 Denied


(505(q) Certification)
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2011-P-0931 Upsher-Smith Extended-release Topiramate Drug


Laboratories, Inc.

FDA-2011-P-0840 Perrigo Company Prevacid®24HR (lansoprazole) Drug


Capsules

FDA-2011-P-0823 AstraZeneca CRESTOR (rosuvastatin Drug


Pharmaceuticals LP calcium) Tablets

FDA-2011-P-0767 Somaxon SILENOR (doxepin) Drug


Pharmaceuticals, Inc.

FDA-2011-P-0702 Warner Chilcott, LLC & DORYX (doxycycline hyclate) Drug


Mayne Pharmaceuticals Delayed-Release Tablet, 150
International Pty Ltd. mg

FDA-2011-P-0663 AstraZeneca SEROQUEL XR (quetiapine Drug


Pharmaceuticals LP fumarate) Extended-release
Tablets

FDA-2011-P-0662 AstraZeneca SEROQUEL (quetiapine Drug


Pharmaceuticals LP fumarate) Tablets

FDA-2011-P-0654 Acorda Therapeutics, ZANAFLEX (tizanidine HCl) Drug


Inc. Capsules

FDA-2011-P-0610 Abbott Laboratories ANDROGEL (testosterone gel) Drug

FDA-2011-P-0593 LEO Pharma, Inc. DOVONEX Cream Drug


(calcipotriene 0.005%)

FDA-2011-P-0575 Warner Chilcott ASACOL (mesalamine) Drug


Company, LLC Delayed-Release Tablets

FDA-2011-P-0565 LEO Pharma, Inc. TACLONEX Ointment & Scalp Drug


(calcipotriene 0.005% and
betamethasone dipropionate
0.064%)

FDA-2011-P-0482 Novo Nordisk VAGIFEM (estradiol vaginal Drug


tablets)
FDA-2011-P-0482 Novo Nordisk VAGIFEM (estradiol vaginal Drug
tablets)

FDA-2011-P-0450 MSMB Capital LYMPHOSEEK Drug


Management LLC

FDA-2011-P-0433 Lehigh Valley Oxycodone HCl Drug


Technologies, Inc. &
Glenmark Generics,
Inc. USA

FDA-2011-P-0227 Intendis, Inc. FINACEA (azelaic acid) Gel, Drug


15%

FDA-2011-P-0128 ISTA Pharmaceuticals, BROMDAY/XIBROM Drug


Inc. (bromfenac ophthalmic
solution)

FDA-2011-P-0127 Baxter Healthcare SA SUPRANE (desflurane) Drug

FDA-2011-P-0120 Pronova LOVAZA (omega-3-acid ethyl Drug


esters)

FDA-2011-P-0087 Navinta LLC VENOFER (iron sucrose) Drug

FDA-2011-P-0086 Johnson & Johnson RISPERDAL CONSTA Drug


Pharmaceutical (risperidone) LONG-ACTING
Research, LLC INJECTION
FDA-2011-P-0072 Navinta LLC VENOFER (iron sucrose) Drug

FDA-2011-P-0045 Purdue Pharma L.P. REMOXY (oxycodone) Drug


Controlled-release Capsules
Petition Tracker
LAST UPDATED: 5/26/2015

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/28/2011 6/25/2012 Denied


(505(q) Certification)

Citizen Petition 11/18/2011 5/16/2012 Denied


(505(q) Certification)

Citizen Petition 11/14/2011 5/11/2012 Denied


(505(q) Certification)

Citizen Petition 10/20/2011 4/17/2012 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 9/23/2011 2/8/2012 Denied


(505(q) Certification)

Citizen Petition 9/9/2011 3/7/2012 Denied


(505(q) Certification)

Citizen Petition 9/9/2011 3/7/2012 Denied


(505(q) Certification)

Citizen Petition 9/7/2011 2/3/2012 Denied


(505(q) Certification)

Citizen Petition 8/19/2011 7/23/2014 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 8/11/2011 1/18/2012 Denied


(505(q) Certification)

Citizen Petition 8/1/2011 11/30/2011 Granted


(505(q) Certification)

Citizen Petition 7/22/2011 1/18/2012 Denied


(505(q) Certification)

Citizen Petition 6/17/2011 12/12/2011 Pending; FDA does


(505(q) Certification) not consider this a
505(q) petition
Citizen Petition
(505(q) Certification)

5/22/2015 Granted in part;


Denied in part

Citizen Petition 6/7/2011 12/2/2011 Pending; FDA does


(505(q) Certification) not consider this a
505(q) petition

Citizen Petition 5/31/2011 11/21/2011 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 3/30/2011 9/26/2011 Pending; FDA does


(505(q) Certification) not consider this a
505(q) petition
6/22/2012 Granted in part;
Denied in part

Citizen Petition 3/1/2011 5/11/2011 Denied


(505(q) Certification)

Citizen Petition 3/1/2011 6/7/2011 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 2/28/2011 5/11/2011 Granted


(505(q) Certification)

Citizen Petition 2/10/2011 8/8/2011 Denied


(505(q) Certification)

Citizen Petition 2/10/2011 Pending; FDA does


(505(q) Certification) not consider this a
505(q) petition
Citizen Petition 2/8/2011 Withdrawn
(505(q) Certification) (resubmitted as FDA-
2011-P-0087)

Citizen Petition 1/14/2011 7/13/2011 Denied


(505(q) Certification)
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2010-P-0648 G. Pohl-Boskamp NITROLINGUAL PUMPSTRAY Drug


GmbH & Company KG (nitroglycerin lingual spray)

FDA-2010-P-0642 Teva Neuroscience COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2010-P-0625 ISTA Pharmaceuticals, XIBROM (bromfenac Drug


Inc. ophthalmic solution)

FDA-2010-P-0624 Cubist CUBCIN (daptomycin for Drug


Pharmaceuticals, Inc. injection)

FDA-2010-P-0614 Mutual Pharmaceutical COLCRYS (colchicine) Tablets Drug


Company, Inc.

FDA-2010-P-0613 Watson Laboratories, ANDRODERM (testosterone Drug


Inc. transdermal system)

FDA-2010-P-0574 Beckloff Associates FAZACLO (clozapine) Orally Drug


Disintegrating Tablets

FDA-2010-P-0570 Nycomed US, Inc. CUTIVATE (fluticasone Drug


propionate) Lotion

FDA-2010-P-0561 Lupin Atlantis Holdings, ANTARA (fenofibrate) Drug


S.A. Capsules
FDA-2010-P-0549 Lupin Ltd. COMBIVIR (lamivudine; Drug
zidovudine) Tablets,
150mg/300 mg

FDA-2010-P-0546 Beckloff Associates FAZACLO (clozapine) Orally Drug


Disintegrating Tablets

FDA-2010-P-0545 UCB, Inc. XYZAL (levocetirizine Drug


dihydrochloride)

FDA-2010-P-0531 Peptimmune, Inc. COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2010-P-0518 Hoffmann-La Roche, BONIVA (ibandronate sodium) Drug


Inc. Once-Monthly

FDA-2010-P-0438 Dr. Reddy's FOSAMAX PLUS D Drug


(alendronate sodium;
cholecalciferol) Tablets; MaPP
5240.3

FDA-2010-P-0430 Eisai, Inc. ARICEPT (donepezil HCl) Drug

FDA-2010-P-0403 Novo Nordisk VAGIFEM (estradiol vaginal Drug


tablets)

FDA-2010-P-0396 Cephalon, Inc. FENTORA (fentanyl) Buccal Drug


Tablets

FDA-2010-P-0383 Cephalon, Inc. FENTORA (fentanyl) Buccal Drug


Tablets

FDA-2010-P-0317 Teva Neuroscience Albuterol Sulfate HFA Drug


Inhalation Aerosol Drug
Products

FDA-2010-P-0309 Shire Development Inc. FOSRENOL (lanthanum Drug


carbonate) Chewable Tablets

FDA-2010-P-0255 Osmotica Venlafaxine HCl Extended- Drug


Pharmaceutical Corp. Release Tablets

FDA-2010-P-0243 Endo Phannaceuticals OPANA (oxymorphone HCl) Drug


Inc. Tablets & OPANA
(oxymorphone HCl) Extended-
Release Tablets

FDA-2010-P-0223 Genzyme Corp. HECTOROL (doxercalciferol) Drug


Injection
FDA-2010-P-0216 Flamel Technologies COREG CR (carvedilol Drug
S.A. phosphate) Extended-release
Capsules

FDA-2010-P-0196 Abbott Laboratories ANDROGEL (testosterone gel) Drug

FDA-2010-P-0188 Actavis Elizabeth LLC ADDERALL XR (amphetamine Drug


combination extended-release
capsules)

FDA-2010-P-0111 Warner Chilcott ASACOL (mesalamine) Drug


Company, LLC Delayed-Release Tablets

FDA-2010-P-0092 Lupin Atlantis Holdings, ANTARA (fenofibrate) Drug


S.A. Capsules

FDA-2010-P-0087 Sandoz, Inc. LYRICA (Pregabalin) Capsules Drug

FDA-2010-P-0082 Actavis Elizabeth, LLC KADIAN (morphine sulfate) Drug


Extended-Release Capsules

FDA-2010-P-0069 Kremers Urban, LLC Highly Potent Pharmaceutical Drug


Products

FDA-2010-P-0017 Kremers Urban, LLC Highly Potent Pharmaceutical Drug


Products
Petition Tracker
LAST UPDATED: 12/11/2015

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/21/2010 6/16/2011 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

10/31/2013 Granted in part;


Denied in part

Citizen Petiton 10/7/2012 10/31/2013 Granted in part;


(Petition for Stay) Denied in part

Citizen Petition 12/10/2010 6/8/2011 Denied


(505(q) Certification)

Citizen Petition 12/3/2010 3/1/2011 Withdrawn


(505(q) Certification)

Citizen Petition 12/7/2010 6/1/2011 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 11/26/2010 5/25/2011 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 11/24/2010 2/10/2014 Denied


(505(q) Certification)

Citizen Petition 11/3/2010 5/6/2015 Denied


(505(q) Certification)

Citizen Petition 10/29/2010 4/27/2011 Denied


(505(q) Certification)

Citizen Petition 10/21/2010 2/17/2011 Withdrawn


(505(q) Certification)
Citizen Petition 10/19/2010 4/8/2011 Pending; FDA interim
(505(q) Certification) response indicates
not a 505(q) petition

5/25/2011 Denied

Citizen Petition 10/14/2010 10/29/2010 Withdrawn


(505(q) Certification)

Citizen Petition 10/15/2010 2/24/2011 Denied


(505(q) Certification)

Citizen Petition 10/4/2010 3/29/2011 Denied


(505(q) Certification)

Citizen Petition 9/29/2010 2/22/2011 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 8/16/2010 2/11/2011 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

4/8/2011 Withdrawn

Citizen Petition 8/12/2010 11/26/2010 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 7/27/2010 6/17/2011 Withdrawn


(505(q) Certification)

Citizen Petition 7/23/2010 1/7/2011 Denied


(505(q) Certification)

Citizen Petition 7/13/2010 1/7/2011 Denied


(505(q) Certification)

Citizen Petition 6/16/2010 12/8/2015 Withrawn


(505(q) Certification)

Citizen Petition 6/14/2010 12/8/2010 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 5/21/2010 11/17/2010 Denied


(505(q) Certification)

Citizen Petition 5/13/2010 11/8/2010 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 4/22/2010 10/19/2010 Granted


(505(q) Certification)
Citizen Petition 4/19/2010 10/15/2010 Granted in part;
(505(q) Certification) Denied in part

Citizen Petition 4/9/2010 10/4/2010 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 4/7/2010 10/4/2010 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

6/21/2012 Withdrawn

Citizen Petition 2/23/2010 8/20/2010 Granted in part;


(505(q) Certification) Denied in part

Petition for 9/17/2010 11/8/2012 Denied


Reconsderation

Citizen Petition 2/17/2010 8/13/2010 Denied


(505(q) Certification)

Citizen Petition 2/12/2010 7/30/2010 Denied


(505(q) Certification)

Citizen Petition 2/5/2010 7/19/2010 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 1/27/2010 7/21/2010 Denied


(505(q) Certification)

Citizen Petition 1/6/2010 1/27/2010 Withdrawn


(505(q) Certification)
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2009-P-0601 Navinta LLC NAROPIN (ropivacaine HCl Drug


monohydrate) Injection

FDA-2009-P-0597 GlaxoSmithKline Inhalation Products Containing Drug


Fluticasone Propionate and/or
Salmeterol Xinafoate

FDA-2009-P-0580 Arent Fox Articaine Drug

FDA-2009-P-0578 Dey Pharma, L.P. EPIPEN (epinephrine) Auto- Drug


Injector

FDA-2009-P-0555 Teva Neuroscience COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2009-P-0522 Lupin Pharmaceuticals, SUPRAX (cefixime) Oral Drug


Inc. Suspension

FDA-2009-P-0446 Virginia Commonwealth Buprenorphine HCl Drug


University

FDA-2009-P-0423 Graceway ALDARA (imiquimod) Cream Drug


Pharmaceuticals

FDA-2009-P-0415 Mylan Inc. DURAGESIC (fentanyl) Drug

FDA-2009-P-0411 Sandoz Inc. ACTOS (pioglitazone HCl) Drug


Tablets & ACTOPLUS MET
(pioglitazone HCl; metformin
HCl) Tablets

FDA-2009-P-0403 Osmotica Venlafaxine HCl Extended- Drug


Pharmaceutical Corp. Release Tablets

FDA-2009-P-0398 Pronova LOVAZA (omega-3-acid ethyl Drug


esters)

FDA-2009-P-0379 Mallinckrodt, Inc. Tyco RESTORIL (temazepam) Drug


Healthcare Group LP Capsules

FDA-2009-P-0364 Graceway ALDARA (imiquimod) Cream Drug


Pharmaceuticals
FDA-2009-P-0356 Osmotica Venlafaxine HCl Extended- Drug
Pharmaceutical Corp. Release Tablets

FDA-2009-P-0334 Reckitt Benckiser MUCINEX (guaifenesin) Drug


Group plc products

FDA-2009-P-0326 Apotex Inc. ARICEPT (donepezil) Drug

FDA-2009-P-0325 Reckitt Benckiser SUBUTEX (buprenorphine) Drug


Pharmaceuticals, Inc. and SUBOXONE
(buprenorphine; naloxone)

FDA-2009-P-0289 Reckitt Benckiser SUBUTEX (buprenorphine) Drug


Pharmaceuticals Inc. and SUBOXONE
(buprenorphine; naloxone)

FDA-2009-P-0272 Sanofi-aventis TAXOTERE (docetaxel) Drug


Injection

FDA-2009-P-0266 Dr. Reddy's REMS and Biostudy Sample Drug

FDA-2009-P-0265 Galderma DIFFERIN (adapalene) Drug

FDA-2009-P-0225 Galderma ORACEA (doxycline) Drug

FDA-2009-P-0223 URL Mutual SKELAXIN (metaxalone) Drug


Tablets

FDA-2009-P-0216 Ortho-Biotech Products, DOXIL (doxorubicin HCl) Drug


Liposome Injection

FDA-2009-P-0183 Procter & Gamble OTC Proton Pump Inhibitors Drug

FDA-2009-P-0154 UNC Gillings School of SUBUTEX (buprenorphine) Drug


Global Public Health and SUBOXONE
(buprenorphine; naloxone)
FDA-2009-P-0123 TESTIM (testosterone Drug
Auxilium Pharm., Inc.
transdermal gel, 1%)
FDA-2009-P-0120 Stiefel Laboratories, EVOCLIN (clindamycon Drug
Inc. phosphate)
FDA-2009-P-0115 Mitsuishi / Oblan Spivak Argatroban Drug Substance Drug

FDA-2009-P-0089 Novo Nordisk VAGIFEM (estradiol vaginal Drug


tablets)

FDA-2009-P-0103 The Roche Group CELLCEPT (mycophenolate Drug


mofetil)

FDA-2009-P-0081 Medicis (Hunton & SOLODYN (minocycline HCl) Drug


Williams)

FDA-2009-P-0059 Eurand Porcine-Derived Pancreatic Drug


Enzyme Product

FDA-2009-P-0042 Mitsuishi / Oblan Spivak Argatroban Drug Substance Drug

FDA-2009-P-0038 Mayne Pharma & DORYX (doxycycline hyclate) Drug


Warner Chilcott

FDA-2009-P-0040 King Pharm. Sumatriptan Succinate Drug


Injection
Petition Tracker
LAST UPDATED: 5/26/2015

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/22/2009 6/17/2010 Granted


(505(q) Certification)

Citizen Petition 12/16/2009 6/4/2010 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

Citizen Petition 12/3/2009 5/25/2010 Denied


(505(q) Certification)

Citizen Petition 12/2/2009 5/27/2010 Denied


(505(q) Certification)

Citizen Petition 11/13/2009 5/11/2010 Denied


(505(q) Certification)

Citizen Petition 10/22/2009 5/19/2009 Granted


(505(q) Certification)

Citizen Petition 9/16/2009 3/15/2010 Denied


(505(q) Certification)

Citizen Petition 8/28/2009 2/24/2010 Denied


(505(q) Certification)

Citizen Petition 8/27/2009 2/22/2010 Denied


(505(q) Certification)

Citizen Petition 8/25/2009 3/15/2010 Granted (Not


(505(q) Certification) considered by FDA to
be a 505(q) citizen
petition)

Citizen Petition 8/20/2009 2/16/2010 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 8/4/2009 1/28/2010 Denied


(505(q) Certification)

Citizen Petition 8/5/2009 2/1/2010 Denied


(505(q) Certification)

Citizen Petition 7/30/2009 1/26/2010 Denied


(505(q) Certification)
Citizen Petition 7/27/2009 1/21/2010 Denied
(505(q) Certification)

Citizen Petition 7/16/2009 1/12/2010 Denied


(505(q) Certification)

Citizen Petition 7/15/2009 1/8/2010 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

11/26/2010 Granted in part;


Denied in part

Citizen Petition 7/14/2009 10/8/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 6/22/2009 7/10/2009 Withdrawn


(505(q) Certification)

Citizen Petition 6/16/2009 12/9/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 6/10/2009 12/3/2009 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

8/7/2013 Granted in part;


Denied in part

Citizen Petition 6/10/2009 12/1/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 5/15/2009 11/16/2009 Denied


(505(q) Certification)

Citizen Petition 5/14/2009 11/6/2009 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

Citizen Petition 5/8/2009 10/30/2009 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

2/4/2013 Granted in part;


Denied in part

Citizen Petition 4/9/2009 10/2/2009 Denied


(505(q) Certification)

Citizen Petition 3/17/2009 9/3/2009 Denied


(505(q) Certification)
Citizen Petition 2/27/2009 8/26/2009 Granted in part;
(505(q) Certification) Denied in part

Citizen Petition 2/24/2009 3/17/2009 Denied


(505(q) Certification)

Citizen Petition 2/23/2009 8/19/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 2/18/2009 8/14/2009


(505(q) Certification)
Pending; FDA interim
response indicates
not a 505(q) petition
5/22/2015 Granted in part;
Denied in part

Citizen Petition 2/17/2009 3/17/2009 Denied


(505(q) Certification)

Citizen Petition 2/13/2009 3/17/2009 Denied


(505(q) Certification)

Citizen Petition 2/9/2009 4/30/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 1/30/2009 2/23/2009 Withdrawn


(505(q) Certification) (resubmitted as FDA-
2009-P-0115)

Citizen Petition 1/29/2009 3/17/2009 Denied


(505(q) Certification)

Citizen Petition 1/30/2009 7/29/2009 Granted in part;


(505(q) Certification) Denied in part
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2008-P-0654 Procter & Gamble OTC Omeprazole/Sodium Drug


Bicarbonate

FDA-2008-P-0621 EKR Therapeutics Nicardipine HCl Injection Drug

FDA-2008-P-0625 Ista Pharm. Topical Opthalmic Rx Drug Drug


Products

FDA-2008-P-0616 Upsher-Smith Salmon-Calcitonin (Synthetic Drug


or Recombinant)

FDA-2008-P-0599 Procter & Gamble OTC Omeprazole/Sodium Drug


Bicarbonate

FDA-2008-P-0586 Mayne Pharma Intl. & Doxycycline Hyclate Relayed- Drug


Warner Chilcott Release Tablets

FDA-2008-P-0587 Warner Chillcot Norethrindrone acetate/ethinyl Drug


estradiol/ferrous fumerate

FDA-2008-P-0529 Teva Neuroscience COPAXONE (Glatiramer Drug


Acetate) Injection

FDA-2008-P-0532 Shire Pharm. Carbamazepine Drug

FDA-2008-P-0524 Luitpold Pharm. Ferumoxytol Drug

FDA-2008-P-0507 Shire Pharm. Mesalamine Drug


FDA-2008-P-0441 Warner Chilcott Norethrindrone acetate/ethinyl Drug
estradiol/ferrous fumerate

FDA-2008-P-0442 Mutual Pharm. Colchicine Indicated for Drug


Prophylaxis of Gouty Flare

FDA-2008-P-0411 Caraco Pharm. Labs., PRANDIN (repaglinide) Drug


Ltd.

FDA-2008-P-0374 Mayne Pharm. Intl. & Doxycycline Hyclate Drug


Warner Chilcott

FDA-2008-P-0366 Purdue Pharm. Oxycodone Drug

FDA-2008-P-0365 ISTA Pharm. Various Drugs (imported API) Drug

FDA-2008-P-0368 ISTA Pharm. Bromfenac Sodium Ophthalmic Drug


Solution

FDA-2008-P-0343 Novo Nordisk PRANDIN (repaglinide) Drug

FDA-2008-P-0329 Osmotica Pharm. Venlafaxine HCl Extended- Drug


Release Tablets

FDA-2008-P-0318 Mylan Pharm. Nisoldipine Drug

FDA-2008-P-0304 King Pharm. Ramipril Drug

FDA-2008-P-0300 Salix Pharm Rifaximin Drug

FDA-2008-P-0236 Altus Pharm. Pancreatin/Pancrealipase Drug


FDA-2008-P-0250 Altus Pharm. Pancreatin/Pancrealipase Drug

FDA-2008-P-0185 Medicis Pharm. Corp. Minocycline HCl Drug

FDA-2008-P-0187 Ferring B.V. Pancreatin/Pancrealipase Drug

FDA-2008-P-0122 Bristol Myers Squibb Technetium TC-99M Seseamibi Drug

FDA-2008-P-0117 Apotex Clopidogrel Bisulfate Drug

FDA-2008-P-0126 Olson & Cepuritis, Ltd. Pancreatin/Pancrealipase Drug


(Ferring B.V.)

FDA-2008-P-0069 Watson Labs Irinotecan HCl Drug

FDA-2008-P-0052 Mutual Pharm. Co. Metaxalone Drug


Petition Tracker
LAST UPDATED: 1/8/2013

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/16/2008 6/12/2009 Denied


(505(q) Certification)

Citizen Petition 12/1/2008 5/29/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 12/3/2008 6/2/2009 Denied


(505(q) Certification)

Petition for 7/1/2009 Pending


Reconsideration

Citizen Petition 11/25/2008 5/21/2009 Denied


(505(q) Certification)

Citizen Petition 11/18/2008 12/16/2008 Withdrawn


(505(q) Certification) (resubmitted as FDA-
2008-P-0654)

Citizen Petition 11/4/2008 5/1/2009 Granted in part;


(505(q) Certification) Denied in part

Citizen Petition 11/4/2008 4/24/2009 Granted


(505(q) Certification)

Citizen Petition 9/26/2008 3/25/2009 Denied


(505(q) Certification)

Citizen Petition 10/2/2008 3/31/2009 Denied


(505(q) Certification)

Citizen Petition 9/24/2008 3/23/2009 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

6/30/2009 Denied

Citizen Petition 9/11/2008 3/9/2009 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

8/20/2010 Granted in part;


Denied in part
Petition for 9/17/2010 11/8/2012 Denied
Reconsideration

Citizen Petition 8/5/2008 11/20/2008 Withdrawn;


(505(q) Certification) Resubmitted as FDA-
2008-P-0587
Citizen Petition 8/4/2008 10/8/2009 Withdrawn; FDA
(505(q) Certification) interim response
indicates not a 505(q)
petition
Citizen Petition 7/16/2008 12/4/2008 Granted
(505(q) Certification)

Amended Citizen 7/22/2008 12/4/2008 Granted


Petition

Citizen Petition 6/26/2008 11/14/2008 Withdrawn


(505(q) Certification)

Citizen Petition 6/23/2008 12/19/2008 Denied


(505(q) Certification)

Citizen Petition 6/23/2008 12/19/2008 Denied


(505(q) Certification)

Citizen Petition 6/23/2008 12/15/2008 Pending; FDA interim


(505(q) Certification) response indicates
not a 505(q) petition

5/11/2011 Granted in part;


Denied in part

Citizen Petition 6/9/2008 12/4/2008 Denied


(505(q) Certification)

Petition for Stay of 12/20/2008 6/16/2009 Denied as Moot


Action

Petition for 12/19/2008 6/16/2009 Denied as Moot


Reconsideration

Citizen Petition 5/30/2008 11/26/2008 Granted


(505(q) Certification)

Citizen Petition 5/27/2008 8/7/2008 Withdrawn


(505(q) Certification)

Citizen Petition 5/19/2008 6/18/2008 Denied


(505(q) Certification)

Citizen Petition 5/14/2008 11/10/2008


(505(q) Certification) Pending; FDA interim
response indicates
not a 505(q) petition
Citizen Petition 4/16/2008 10/10/2008 Denied
(505(q) Certification)
Citizen Petition 4/16/2008 10/10/2008 Granted in part;
(505(q) Certification) Denied in part.

Citizen Petition 3/20/2008 2/3/2009 Denied


(505(q) Certification)

Citizen Petition 3/20/2008 9/10/2008 Denied


(505(q) Certification)

Citizen Petition 2/14/2008 8/13/2008 Denied


(505(q) Certification)

Citizen Petition 2/13/2008 5/17/2012 Denied (Not a FDC


(505(q) Certification) Act 505(q) petition)

Citizen Petition 2/19/2008 9/10/2008 Closed. Reopened


(505(q) Certification) as FDA-2008-P-
0187.
Citizen Petition 1/30/2008 7/28/2008 Denied
(505(q) Certification)

Citizen Petition 1/23/2008 4/18/2008 Denied


(505(q) Certification)
FDA Citizen Petition Tracker
Docket No. Petitioner Product Name/Issue Category

FDA-2007-P-0235 Mutual Pharm. Co. Felodipine Extended-Release Drug


Tablets USP

FDA-2007-P-0123 Mutual Pharm. Co. Felodipine Extended-Release Drug


Tablets

FDA-2007-P-0418 Cobalt Acarbose Drug

FDA-2007-P-0183 Purdue Pharm. Oxycodone HCl Drug

FDA-2007-P-0169 Unimed Dronabinol Drug


Petition Tracker
LAST UPDATED: 1/8/2013

Petition Type Receipt Date Decision Date Decision

Citizen Petition 12/20/2007 4/17/2008 Denied


(505(q) Certification)

Citizen Petition 11/30/2007 4/17/2008 Denied


(505(q) Certification)

Citizen Petition 11/9/2007 5/7/2008 Granted in part;


(505(q) Certification) Denied in part

Petition for Stay of 11/9/2007 5/7/2008 Denied.


Action

Petition for Stay of 10/15/2007 3/24/2008 Denied


Action (505(q)
Certification)

Peition for 4/1/2008 Pending (no


Reconsideration certification included;
probably not a FDC
Act 505(q) petition)

Citizen Petition 10/29/2007 4/25/2008 Denied


(505(q) Certification)

You might also like